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Executive Summary 
 
 
 Health and Social Care Evaluations (HASCE) at the University of Cumbria was 
commissioned by Bay Health and Care Partners, through NHS England Vanguard funding, 
to evaluate new models of care in Morecambe Bay. The local evaluation focused on 
understanding the context of the programme, the changes it has brought about, and 
which components of the care model really make a difference. The evaluation began in 
October 2016 and was completed in September 2018.  
 
 This report summarises the findings of the second stage of evaluation, which focused on 
the Morecambe Bay Respiratory Network (MBRN). In addition to the data presented in 
the Stage 2 Early Findings Report, this report is informed by data from interviews with 
patients, further staff interviews and an economic analysis of resource use. 
 
 The evaluation demonstrates that the MBRN has so far been a successful new model of 
care, with the potential to become a self-funding initiative which reduces secondary care 
activity, improves self-care amongst patients and enhances the learning and upskilling of 
staff. 
 
 The model has developed ways of overcoming a number of problems and tensions 
identified with the implementation of NCMs, which were documented in HASCE’s 12 
Month Report focusing on the BCT Vanguard programme: in particular, its model of 
leadership and its emphasis on communication. 
 
 From the data that is available for this evaluation, the running cost of the MBRN has been 
calculated as amounting to approximately £1.9m pounds year, or £160k per month.  
 
 Possible tariff reductions in secondary care from reduced NEL admissions and NEL bed-
days as well as reduced outpatient clinic capacity amount to over £2.6m per year, or £221k 
per month. This would arrive at a net savings to the health system of approximately 
£745k per year, or £60k per month. 
 In summary, all indications point to the MBRN being a cost-effective step change in 
delivering respiratory services in the Morecambe Bay area. 
 
 The report recommends that the model is continued to be supported by Bay Health and 
Care Partners. The economic evaluation has also shown that in order to deliver the 
savings to the health economy that are certainly possible through an effective MBRN, it 
has to be fully implemented, including its community services.  
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1   Introduction 
 
 
1.1 The New Care Model Evaluation 
 
In 2015, 50 vanguard sites were selected to develop new models of care. The new care models 
(NCMs) were a key component of the strategy set out in the Five Year Forward View1 to prevent 
widening gaps in health and wellbeing, care quality, and funding and efficiency. Morecambe 
Bay’s Better Care Together (BCT) programme, a partnership set up in 2012 to review health 
services, was selected as one of these vanguards. As an integrated Primary and Acute System 
(PACS) vanguard, it aimed to:  
 Improve primary and acute medicine; and 
 Develop preventative community-based services. 
 
Evaluation is a key component of all NCMs, and in addition to a national evaluation, which is 
measuring performance against a core metric set, each vanguard was required to commission a 
local evaluator to identify why and how impacts are being created. Health and Social Care 
Evaluations (HASCE) at the University of Cumbria was commissioned by Bay Health and Care 
Partners to evaluate the BCT PACS vanguard.  
 
The local evaluation focused on understanding the context of the programme, the changes it has 
brought about, and which components of the care model really make a difference. The 
evaluation began in October 2016 and was completed in September 2018.  
 
The evaluation was split into two distinct stages:  
 The first year of evaluation examined the Vanguard activities across Morecambe Bay. 
Findings from this stage of the evaluation were presented in the 12-month Evaluation 
Report in October 2017. 
 Following discussion with the evaluation commissioners, the second year of 
evaluation focused on the Morecambe Bay Respiratory Network as an example of an 
NCM. The emerging findings from this stage of evaluation were presented in the 
Stage 2 Early Findings Report in April 2018.  
 
1.2 Better Care Together and the Vanguard 
 
The BCT programme brought together 12 partners (now 10, following the merger of two Clinical 
Commissioning Groups and recent transfer of CPFT staff into UHMB in April 2018) to tackle the 
                                                             
1 NHS England (2014). NHS Five Year Forward View. https://www.england.nhs.uk/publication/nhs-five-year-
forward-view/ 
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challenges facing the provision of health care in Morecambe Bay. These challenges included an 
ageing population, increased demand on resources, finance and issues with care quality and 
safety. BCT identified a population based approach as key to improving care and promoting 
wellbeing2 and achieving the Five Year Forward Triple Aim:  
 improving population health; 
 improving the individual experience of care; and 
 reducing per capita health and care spend. 
 
In 2015, BCT was allocated £4.59 million to develop the PACS new model of care. The PACS model 
is based on GP registered population and aims to bring together health and care providers to 
improve physical, mental, social health and wellbeing. Its scope includes primary, community, 
mental health, social and acute care.3 Key features of the BCT vanguard approach included: 
 the establishment of 12 Integrated Care Communities (ICCs) (now 11 as Garstang has 
realigned with FWCCG) that bring together local health and care organisations. The ICCs 
are based on GP practice populations and, through integrating services, aim to enable the 
provision of more care out of hospitals and self-management;  
 the use of technology, such as telehealth, to increase the accessibility of care amongst 
more isolated groups and communities; 
 increasing GP access to hospital specialists through the Advice and Guidance system;  
 work with local communities through initiatives with children and outreach work at 
public events; and 
 using a workstream approach to develop new models in areas such as ophthalmology, 
Women’s and Children’s services and prescribing. 
 
1.3 Two Stages of Evaluation 
 
The first year of the evaluation collected qualitative data on activities across the vanguard to 
explore the emerging changes and their associated outcomes. The evaluation raised several 
questions regarding the size, scope and identity of the new models of care being implemented, 
and recommended more detailed and localised measures to be used to capture the changes that 
were occurring.  Following the evaluator’s interim report on 18/04/2017, evaluators and 
commissioners discussed the need for the independent evaluation to focus on specific activities 
in more comprehensive detail.  
 
This led to the identification and recommendation of three specific areas which would inform 
both the tail-end of the first twelve-month project, and the continuation of the evaluation project 
across 2017-18. These were the development of Integrated Care Communities (ICCs) in Barrow 
                                                             
2 The Better Care Together Strategy for the Future for health and care services in Morecambe Bay. (2015) 
https://www.uhmb.nhs.uk/files/bct-publications/Better-Care-Together-Plan.pdf p.6 
3 https://www.england.nhs.uk/wp-content/uploads/2016/09/pacs-framework.pdf  
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Town, Bay and East; and the evaluation of a specific intervention within each of these: from the 
Respiratory pathway (Barrow Town), Paediatrics pathway (Bay) and Frailty pathway (East). 
 
However, following the wider re-focusing of Bay Health and Care Partners’ activities, it was 
agreed at the BCT Research and Evaluation Group that concentrating evaluation resources on the 
new model of respiratory care developed by the Morecambe Bay Respiratory Network (MBRN), 
which impacted across a greater number of ICCs, would provide opportunities for learning.  
 
1.4 The Morecambe Bay Respiratory Network 
 
It is important to note that, while the MBRN received partial funding through the Vanguard 
programme, it was not part of the Better Care Together programme design; but shared in its 
aims the principles of an NCM. As described in the case for change document presented to the 
Morecambe Bay Accountable Care System’s Delivery Group in August 20174, the MBRN sought to 
deliver a new model of care “to proactively and consistently manage respiratory disease to a high 
standard across Morecambe Bay.”  The key goals of the new model are:5 
 flexible network model allowing each ICC to develop their own way of working; 
 all patients will be diagnosed accurately to establish the nature of their respiratory 
condition; 
 patients with respiratory conditions should have all their routine care provided and 
managed within ICCs – the aim is to reduce outpatient attendances by 50-100% by the end 
of 2018; 
 all patients will have a personal care plan that is understood and owned by the 
patient/carer; 
 all patients will have an annual review as a minimum (whole person Multi-Disciplinary 
Team (MDT) based review); 
 high quality care will be provided by an extended MDT in each ICC, combining the 
appropriate expertise from both secondary and primary care;  
 patients with exacerbations should also be managed within ICCs in the vast majority of 
cases – aim to reduce non-elective attendances by other 50% by the end of 2018; and 
 the opportunity for UHMB to develop additional specialist clinics to repatriate care for 
difficult asthma currently being seen out of area. 
 
At the centre of the model’s design was the development of a community clinic and hospital at 
home service.6 The clinics were to bring consultants and specialist nurses out of the hospital and 
into the community to work with ICC staff. It was expected that this way of working would 
                                                             
4 MBRN (2017). Morecambe Bay ACS Case for Change in Respiratory Services, p.1.  
5 MBRN (2017). Morecambe Bay ACS Case for Change in Respiratory Services, p.1 
6 This description of the MBRN relates to the design presented in the Case for Change documents. Section 
2 provides details of which components have been implemented to date.  
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enable secondary care staff to support and mentor ICC staff. Multi-disciplinary team (MDT) 
discussions were to be built into the clinics, with patients being discussed rather than referred to 
an outpatient clinic. As shown in Figure 1 below, the improvements to respiratory care required 
investment in three separate components. 
 
 
Figure 1: Key Elements of the MBRN Respiratory Model
7
 
 
The implementation of the model was planned in three bundles of activity; in the first, the model 
would be implemented by GP and community services in five ICCs (Barrow Town, Queen Square, 
Lancaster, Morecambe Bay and Carnforth); the second bundle would see the model being rolled 
out in GPs and community services in the remaining six ICCs (Kendal, East, Alfred Barrow, Millom , 
Ulverston, Dalton and Askam, and Grange &  Lakes); and then specialist respiratory and acute 
bed capacity would be reduced in the third activity bundle.  
 
The evaluation was therefore planned to follow the roll-out, using the initial months of data 
collection to examine the work in the first bundle, which had commenced in October 2017, and 
then to compare these to activities in the second bundle as a comparator group. However, the 
roll-out to the second bundle was delayed beyond both its anticipated schedule, and the course 
of the commissioned evaluation time. This placed limits on the evaluation’s data collection 
activities. 
 
 
                                                             
7 Source: Adapted from MBRN (2017). Morecambe Bay ACS. Case for Change in Respiratory Services 
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1.5 About this Report 
 
During the two years of evaluation work, HASCE has gathered the views of over 150 participants 
in interviews and surveys. In addition, the evaluators have run nine workshops and events with 
stakeholders and participants. These include discussion workshops on the main themes of the 
NCM, dissemination and feedback events regarding the evaluation findings, and evaluation 
training and skills workshops to support ongoing improvement across Morecambe Bay health 
economy. 
 
This final report summarises the findings of the second stage of evaluation, and links these to the 
findings presented in the first stage. In addition to the data presented in the Stage 2 Early 
Findings Report, this report is informed by data from interviews with patients, further staff 
interviews and an economic analysis of resource use. 
 
This serves both to continue and develop the evaluation approach detailed in HASCE’s 12 month 
evaluation report, and inform discussions on the future investment in the new respiratory care 
model and its wider roll out. In doing so, the report follows the spirit of the vanguard approach: 
regular sharing of evaluation findings to inform and strengthen delivery.  
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2 The Evaluation Approach 
 
 
2.1 New Models of Care and Evaluation: an Ongoing Discussion 
 
Evaluating new models of care is a complex activity, and debates around the best methods for 
doing so continue to evolve. At the heart of these debates is the need to balance localised 
accounts of change with higher-level performance outcomes, with methodological rigour and 
critical appraisal applied throughout.  
 
The 12 Month Report summarised the main issues for evaluation that programmes as ambitious 
as BCT raised. It also provided a comprehensive account of the methodologies HASCE used to 
address these.8 
 
Like all local evaluations of NCMs, HASCE’s approach is designed to address the question set 
developed by the national NCM team. These questions require an assessment of the context, 
changes, outcomes and active ingredients of the NCM. To do this, a realist methodology has been 
adopted.9 This approach aims to capture ‘what works, for who, and why’, in nuanced detail, over 
and above blunter outcome-focused studies. It does this by identifying the context, mechanisms 
and outcomes associated with programmes of change. The basic premise of this methodology is 
that outcomes are brought about by the steps taken by those delivering a programme (known as 
mechanisms), which take place in particular contexts.  
 
In addition to its attention on the contextual details that affect the success of interventions (or 
otherwise), a key advantage of this method is how it accounts for how the delivery of an NCM 
often depended on a number of overlapping and interconnecting processes taking place. Models 
for change can suffer setbacks at various stages in their implementation, and it is important to 
identify the ‘active ingredients’ which support new models of care, some of which may not be 
immediately apparent. To demonstrate this, the 12 month evaluation report presented an 
expanded version of the realist method.10  
 
The application of this methodology raised a number of questions over the design and 
implementation of the vanguard activities. In contrast, the MBRN benefitted from a clear 
strategic pathway which provided a set of testable hypotheses. However, due to the model being 
only partially implemented, and the delays in this implementation, it was not possible to fully 
integrate the MBRN programme hypotheses with the previous  
 
                                                             
8 HASCE (2017). Local Evaluation of Morecambe Bay PACS Vanguard. 12 Month Report. Chapter 2 
9 See Pawson & Tilley, Realistic Evaluation. London: SAGE (1997). 
10 See HASCE (2017). Local Evaluation of Morecambe Bay PACS Vanguard. 12 Month Report, Chapter 4 
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2.2 Stage 2 Data Collection and Analysis 
 
The evaluation methodology included the following aspects:   
 Qualitative data collection and analysis; 
 An economic impact assessment; and 
 Triangulation with quantitative data provided by the Informatics, Information and 
Innovation (I3) team at University Hospitals of Morecambe Bay Trust (UHMBT). 
 
The data collection strategy for the second stage of evaluation was initially based on the planned 
roll-out of the MBRN across Morecambe Bay, and consisted of the following: 
 
 
 
Further details on how these data collection activities were conducted are detailed in the table 
below: 
  
Data Collection Activity Evaluation Activity  
  
 
Review of baseline and pathway monitoring 
data 
Key respiratory data metrics and indicators are 
being collated into a new respiratory dashboard 
by the Informatics, Information and Innovation 
team at University Hospitals Morecambe Bay 
Trust. The dashboard will present the data 
required to assess the new care model against its 
key performance indicators (KPIs).  
 
 
 
 
At the time of writing this report, the KPIs are still in 
development and the latest working version of the 
dashboard has not been released to the evaluation 
team. Outcome metrics were drawn from separate 
data provided by I3 and from MBRN reports. 
Review of 
baseline and 
pathway 
monitoring 
data 
Analysis of 
minutes of 
key meetings 
Interviews 
with 
strategic 
stakeholders 
Interviews 
with ICC 
respiratory &  
MDT teams 
Interviews 
with 
respiratory 
patients 
Observations 
of MDTs 
11 
 
Data Collection Activity Evaluation Activity  
  
 
Analysis of minutes 
Records of who attended meetings, discussion 
points and agreed actions provide a potentially 
valuable source of data on how the new 
respiratory model has been developed and 
delivered across primary, community and 
secondary services. Meetings that were 
potentially relevant to the evaluation include the 
Bay-wide Respiratory Leadership Group and ICC 
meetings.   
 
 
 
Analysis of minutes for ICC meetings in Barrow 
Town and Queen Square were received for the 
months of October, November and December 2017. 
There were few references to the respiratory care 
model in these minutes and they therefore provide 
little insight into the development and delivery of 
the new model. 
 
 
Interviews with staff (strategic stakeholders, 
ICC respiratory teams and MDT teams) 
Interviews with those involved in the 
development, leadership and delivery of the 
respiratory pathway. The purpose of these in-
depth qualitative interviews was to explore the 
process of developing and delivering the new 
respiratory pathway and perceptions of its 
impact. The topics explored in the interviews are 
shown in Appendix 1.  
 
 
 
37 staff members identified by the MBRN as being 
involved in the delivery of the new model of care 
have been invited to participate in an interview (the 
first invitation was issued in January 2018).  
21 interviews with staff have been completed 
between January and September 2018. The 
interviews have ranged between 15 and 70 minutes 
in duration. Clinicians have reported shorter 
interview times reflecting limited availability during 
the busy winter period. With the permission of 
participants, interviews were audio-recorded and 
then transcribed.  
 
Eight people declined the invitation to take part in 
an interview. Reasons given for non-participation 
include lack of knowledge or involvement in the 
MBRN, lack of time or change in job role.  
 
 
 
Interviews with patients 
In-depth qualitative interviews enable the 
exploration of experiences of care and the 
perceived impact of the changes brought about 
by the new pathway on satisfaction, self-
management, and health and wellbeing.   
 
 
14 patients registered at a GP practice in either 
Queen Square or Lancaster ICC were interviewed. 
Two interviews were conducted face-to-face and 
the remainder by telephone. The average interview 
duration was 23 minutes (the shortest interview 
was 10 minutes and the longest 40 minutes). 
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Data Collection Activity Evaluation Activity  
  
 
Observation of MDTs 
Based on emerging interview findings indicating 
that the MDTs play an important part in reducing 
outpatient appointments and in the 
management of respiratory care more generally, 
observation of MDTs enabled exploration of 
what features are key in enabling/disabling the 
new care model.   
 
 
 
Three MDTs were observed: two in North Lancs and 
one in Barrow. 
Table 1 Data Collection Activities 
 
Following data collection, interviews were anonymised, transcribed and analysed for key themes. 
Themes were organised into contexts, mechanisms and outcomes, and from this the key findings 
were highlighted. These are presented in Chapter 3. 
 
As with the first stage of the evaluation, data collection was not without its challenges. The 
primary challenge was the delay in rolling out the MBRN model, which prevented comparative 
accounts from different ICCs being compiled. Within the Bundle 1 practices, several key 
stakeholders chose not to engage with the evaluation (see Table 1 above). The respiratory 
dashboard was not available at the time of writing the report, which limited the depth of 
triangulation of qualitative and quantitative data available to the evaluation. The report will 
highlight those findings which may have been affected by the data challenges where 
appropriate, and the significances of data quality for the implementation of new models of care 
will be discussed further in Chapter 4. 
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3 Findings 
 
 
This chapter summarises the findings from the second stage of the evaluation, which looked 
exclusively at the Morecambe Bay Respiratory Network. Because the anticipated roll-out of the 
MBRN has been delayed, much of the detailed findings in this chapter have already been 
presented in the 12-Month Report11 and the Stage 2 Early Findings Report,12 and are referenced, 
rather than replicated, here. 
 
The chapter is structured around the original evaluation questions set out by the national New 
Care Models Team, although it should be noted that while the MBRN received vanguard funding, 
it was not designed as part of the Better Care Together programme. As a result, while the 
evaluation has framed the findings in the broader context of the new care models programme, it 
is a smaller and more autonomous development than the BCT-specific interventions. 
 
3.1 What is the context in each vanguard into which new care models have been 
implemented? 
 
The MBRN has been implemented within the context of a changing health landscape. The 12-
Month Report identified five key areas of context into which the new care models were being 
implemented. The Stage 2 Early Findings reported that all of these contexts were also significant 
for the implementation of the MBRN, both in terms of: 
a) the perception that this model, rather than alternative or previous initiatives, was 
necessary to address the respiratory needs of Morecambe Bay; and 
 
b) the possible variations in the implementation of the model across different areas (i.e. 
between North Lancs and Barrow in Bundle 1, and between Bundle 1 and Bundle 2). 
 
The five key contextual areas identified in the 12 Month Report were: 
 
 
Geography and demographics  The challenges associated with low population density with 
diverse, and sometimes isolated, communities were 
commonly cited by participants in their descriptions of the 
NCM. 
 An ageing population with complex and multiple needs was 
recognised as an increasing source of pressure on health and 
social care in all areas.  
 Participants drew direct links between social isolation and 
                                                             
11 HASCE (2017), Local Evaluation of Morecambe Bay PACS Vanguard: 12 Month Report 
12 HASCE (2018), Local Evaluation of Morecambe Bay PACS Vanguard: Stage 2 Early Findings Report 
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care needs; in the absence of regular social contact, there 
was an increased dependence on services. Furthermore, it 
was believed that needs may not be recognised until an 
acute care admission was required. 
 
 
Skill supply 
 
 The retention and recruitment of staff was commonly 
described as a factor affecting both the set up and delivery of 
the NCM. High staff turnover rates were reported across a 
wide range of roles, including commissioning, management 
and clinical. Furthermore, the geographical location, and the 
relative isolation of some communities, created recruitment 
difficulties. 
 Despite staff shortages, participants also identified under-
utilised skills within the existing workforce, and the capacity 
for up-skilling staff through NCM activities. 
 
 
Previous initiatives  Morecambe Bay has been subject to a range of 
transformation programmes, and participants reported that 
this on-going cycle of change had often created cynicism or 
negativity amongst staff and other stakeholders. 
 
 
Organisational cultures 
 
 There was a strong feeling amongst participants that a 
departmentalised culture was prevalent across BCT partners 
and was a key disabler. For some, this related to the 
organisational structure of the NHS. The approach to 
commissioning was attributed with the creation of a 
fragmented service and even competition between primary 
and acute care providers. 
 Different procedures for data collection were also cited as a 
contextual barrier to collating consistent evidence for the 
success of a cross-organisational programme. 
 
 
Availability of resources 
 
 The NCM has been developed in a period of austerity, in 
which the NHS, social care and third sector partners have all 
faced significant financial pressures. University Hospitals of 
Morecambe Bay Trust (UHMBT) faces a significant deficit and 
consequently the need to demonstrate cost saving shaped 
the way programmes within the NCM were commissioned, 
implemented and evidenced. 
 
Table 2 Key contextual themes from the first stage of evaluation 
 
Using the data from staff and patients involved in the MBRN, we can see how these contexts are 
developed in the case of this new model of care. 
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3.1.1 Geography and demographics 
 Quality and Outcomes Framework (QOF) recorded disease prevalence data for 2017 
reports that there are 24,189 patients in the Morecambe Bay CCG area with asthma 
(prevalence 6.77%) and 7,818 with Chronic Obstructive Pulmonary Disease (COPD) 
(prevalence 2.2%). The prevalence for both these diseases is higher than that in England 
(5.91% and 1.85% respectively).13 Some interviewees linked the prevalence of respiratory 
disease to the industrial heritage of some parts of Cumbria, while others also emphasised 
the links between deprivation and respiratory disease or the ageing population more 
generally. Previous industrial production across the area influences population health, 
with, for example, asbestos use and weaving being detrimental to respiratory health. As a 
result, industrial practices can produce unequal health outcomes for some populations in 
North Lancashire and South Cumbria. 
 
 Patient interviews also highlighted the impact of wider social, economic and 
environmental factors that affected patients’ ability to effectively manage their 
respiratory condition. For example, a few interviewees described the importance of a 
good “back up team” (INT069) of friends and family, particularly given the difficulty in 
travelling independently to medical appointments or interpreting test results. Patients 
without such “back up” reported feeling isolated, which in turn led to depression.  
 
 The need for improved social support, amidst current limitations on its provision may 
contribute to poor adherence to clinicians’ advice regarding smoking cessation and self-
management.  Healthcare is received and mediated by varying factors such as familial, 
sociocultural/economic settings and access to social capital and health literacy. Patients' 
health related decisions do not adhere to a biomedical model, nor do they necessarily 
follow a linear path, due to the often complex contexts of their lives. 
 
 Access to specialist services was perceived to be difficult for the more isolated areas of 
Morecambe Bay. For example, one interviewee described how patients in Barrow were 
travelling to Preston and Manchester, which was particularly challenging for older or frail 
patients.  
 
 
3.1.2 Skill supply 
 Staff shortages continue to be an issue in some areas in both primary and secondary care. 
Interviewees reported that ICCs were experiencing GP shortages, which one interviewee 
attributed to a combination of practice mergers and retirement, and that there had been 
four vacant acute respiratory posts for over three years.  
 
                                                             
13 Lancashire County Council (2017). Morecambe Bay CCG Mini Summary Profile 2017/18. 
http://www.lancashire.gov.uk/media/898216/morecambe-bay-mini-summary-profile-2017-18.pdf 
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 As with the wider BCT programme, the geography of South Cumbria was cited as one 
barrier for staff recruitment.  
 
“Unless you live in Barrow it's quite difficult to get to. There's quite a high turnover 
of staff because of the travel and -- in Lancaster you can travel an hour over a lot 
larger area to be in Lancaster.” (INT082) 
 
 Three interviewees commented on the lack of consultants in the Barrow area. The lack of 
consultants was reported to have led to the use of locums and registrars, which in turn 
had led to a rolling programme of outpatient appointments. As one interviewee 
described, Registrars were asking patients to come back for reviews at six monthly 
intervals: 
 
“One of the key things that was coming out was that people were staying on the 
outpatients list for longer than they should, so when registrars are seeing them, 
we're just saying, ‘Come back in six months.’ So people were just staying on this 
rolling basis, which obviously blocks new users coming in. It blocks a lot of the clinics 
with people who really shouldn't be in an acute setting, they should be managed in 
the Primary Care setting.” (INT082) 
 
 Other inefficiencies in the system included duplication between consultants and 
community respiratory teams, where, in at least one case, a patient had an appointment 
with both in two days. 
 
 Participants reported that much of respiratory care had become nurse led in GP practices, 
with a subsequent de-skilling of GPs. Patient interviews also described how they had seen 
more of a Practice Nurse than a GP. They observed that their condition would be 
reviewed but little action taken as a result of this review.   
 
“…they [Practice Nurses] do a review once a year.  But again, I felt it was a little bit 
limited.  They would say for example, your peak flow has gone down, your lung 
capacity has gone down, but they didn't really back it up with anything and they 
didn't really suggest anything to do about it.” (INT074) 
 
 Interviewees described how the capacity of care teams to meet the needs across the Bay 
differed. For example, unlike in North Lancashire, there were no long-term condition 
matrons or oxygen services in South Cumbria. Another commented that locum staff had 
provided respiratory care at the Furness General Hospital for some time, which was 
perceived to have created communication difficulties with secondary care. 
 
 
3.1.3 Previous initiatives 
 Overall, most of the 14 patients interviewed were positive about their experiences of care 
before introduction of the MBRN. When asked to describe their care, they most often 
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referred to their GP surgery. However, there was also evidence that patients had received 
disjointed care and patients described how they felt unsupported when they saw a 
different GP or consultant at each appointment.  
 
 Some patients also reported dissatisfaction with specific interventions. While other 
factors such as poor housing, air pollution and allergies were also reported to affect 
patients’ respiratory condition, the most commonly cited was smoking behaviour. 
Patients recognised the link between smoking and respiratory disease, but one in 
particular was frustrated by repeated smoking cessation advice. Another described how 
the stressors in their life had led to several failed attempts to stop smoking, and that this 
had not necessarily been taken into account in clinic. 
  
 A new model of care was first presented to the BCT vanguard for consideration in 2015 
(prior to the formation of the MBRN). Experiences of this earlier model were often used 
as a point of reference by interviewees and frequent comparisons were made between 
the approaches to developing the two models. The capacity to learn from the failings of 
the previous model were key to many of the MBRN’s initial successes. 
 
 The two fundamental points of difference were the perceived focus on secondary care in 
the earlier model, at the expense of primary and community services; and the lack of 
funding secured by the 2015 iteration which stifled progress and led to no significant 
changes.  
 
 A respiratory pilot project was also implemented in Barrow as part of earlier vanguard 
activity, which has since been implemented in Barrow Town ICC and rolled out to Alfred 
Barrow ICC.14 The project referred patients presenting at Furness General Hospital to a 
respiratory nurse practitioner and then subsequent care was provided by a community 
team.15 Patients were given a self-care plan, help with medicine management and, if 
suitable, were enrolled in a pulmonary rehabilitation programme.  
 
 
3.1.4 Organisational cultures 
 Participants echoed some of the negative themes around organisational silos, the 
competing priorities between primary and secondary care, and the variations of in 
perceptions of how care should be provided.  
 
                                                             
14 Better Care Together (undated). Case Study: Respiratory Care in Barrow-in-Furness: PDSA Cycle.  
http://www.bettercaretogether.co.uk/uploads/files/Respiratory%20Case%20Study%20-
%20June%202017%20BCT%201.0.pdf 
 
15 These ICCs have since been merged. 
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 Conversely, a strong theme emerged from the data around the importance of existing 
networks and collaborations for building a new model of care. 
 
 Some participants cited the lack of communication meant that there was some 
duplication in care and a lack of understanding amongst patients: 
 
“We need to improve communication. Like I say, we work in silos. So, we might see a 
patient in clinic, a week later they might go to the same appointment in GP land, 
with the practice nurse, and we’ve already done it.” (INT090) 
 
 This resonated with some patient’s experiences as well, several of whom commented on 
delays in care, issues with continuity of care, and falling between the gaps of referrals. 
 
“I wish I'd stayed with the same Doctor and I knew what I was doing.  Then they 
refer you to another one and then you go in about six months for different tests 
again, for him to get his own results.  You feel like you're doing everything over and 
over.” (INT075) 
 
 Some patients also highlighted the inconsistency of treatment received, and the 
perceived lack of a joined-up pathway for care. This had, in one case, introduced 
disillusionment with the care pathways. 
 
“It was brilliant at the beginning, but I became disillusioned.  They were constantly 
changing my appointments and I never saw the same person twice.  I felt as if one 
would tell you one thing and one would tell you another.  It was a case of, we'll see 
you in three months.  But the three months appointment was then changed to 
another three months.  I just felt as if I wasn't really getting any support that way.” 
(INT074) 
 
 Staff commonly described inefficiencies or variations in standards of care when 
explaining why a new model for respiratory care was needed. The quality of diagnoses, 
the rationale for referring patients to secondary care and the timeliness of discharge 
were all identified as factors affecting care quality.  
 
 
3.1.5 Availability of resources 
 Participants commented on the high prevalence of respiratory disease across 
Morecambe Bay and felt that secondary, primary and community care services lacked the 
capacity to respond to the demands associated with this, which in turn affected the 
quality of care provided. For example, one interviewee described how long waiting lists 
affected care quality:  
 
“Certainly, in the outpatients we have a large waiting list of patients who are past 
their indicative review date. They should have been seen in three months and it is 
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six, or nine months later and they're coming in. Which causes problems in giving the 
best care.” (INT081) 
 
 Related to this, timely discharge was perceived to be prevented by a lack of capacity in 
primary and community care services, as well as the annual pressures created by 
increased demand in winter. 
 
 In both Barrow and North Lancs a number of community initiatives exist to support 
respiratory patients. For example, patients in with chronic respiratory problems in Barrow 
are able to access support with symptom control, terminal care, transitional care and 
respite care at the local hospice. But participants involved in these programmes felt that 
while these were of benefit to a lot of respiratory patients, resources limited its reach, 
and waiting lists were long.  
 
 The distribution of resources provided a key context for the historical delivery of 
respiratory care across Morecambe Bay. The use of the QOF as a means of funding 
provision was identified by some participants as leading to a less nuanced and in-depth 
approach to respiratory diagnosis: 
 
“GPs have become disenfranchised from providing respiratory care, probably 
because of the QOF in 2004, which said there's only a couple of things you need to 
do for respiratory. GPs made sure those things were done in their practices, and 
they get their QOF money and they tick a box, and because of that it all got shoved 
to Practice Nurses.” (INT091) 
 
 The need for funding decisions to be made regarding the future development of the 
MBRN, and in particular the roll-out from Bundle 1 to Bundle 2 became an increasingly 
significant context for the model of care. This links to findings in the 12 Month Report 
regarding the need for transparency of decision-making at strategic levels. 
 
 It was clear that, as with the stage 1 evaluation, the fundamental resource being used in 
initial setting up of the network was that of good will and enthusiasm for the 
programme. This linked to existing networks and good communication that existed prior 
to the establishment of the network, and throughout its existence. 
 
 
3.2 What key changes have been made and who is being affected by them? How have 
these changes been implemented? Which components of the care model are really 
making a difference? 
 
 
The MBRN’s model of care was presented to the BCT Delivery Group in June 2017 and the roll out 
of the first phase (bundle 1) was approved by the Delivery Group in August 2017. The vanguard 
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investment in this phase of the roll out was £311K.16 In October/November 2017, two MDTs 
became operational and GP leads were appointed in each of the bundle 1 ICCs. 
 
The Stage 2 Emerging Findings Report detailed the changes which had taken place during the 
implementation of the MBRN model, which are summarised here: 
 
 
Establishment Multi-Disciplinary 
Teams (MDTs) 
 A new MDT has been set up in both the North Lancs. and 
Barrow localities. The MDT brings together ICC 
respiratory teams, consultants, specialist nurses 
physiotherapists and other staff to discuss patient cases. 
 
 
Establishment of ICC Respiratory 
Clinics 
 North Lancs ICCs have set up new respiratory clinics in 
their practices.17 
 
 The Barrow practices have so far been less successful in 
establishing clinics, due to their smaller size and 
resources.18 
 
Appointment of GP Leads 
 GP leads have been appointed in each of the Bundle 1 
ICCs. GP leads have been given access to a secondary care 
link team, the MDT, CT imaging and are able to request 
other pulmonary function tests. 
 
 A Lead Clinician pack has been developed which includes 
pathways for diagnosis, exacerbations and management 
of specific disease. 
 
 A full day’s training with a respiratory consultant was also 
offered to GP leads. 
 
 
Establishment of Wider ICC 
Respiratory Team 
 The GP lead has been expected to establish a wider 
respiratory team within the ICC, involving Practice Nurses, 
District Nurses and Community Staff Nurses. 
 
Community Respiratory Teams  While community teams have been involved in the MBRN, 
participants have reported no additional funding has been 
made available, with significant impact on the capacity for 
higher-need patients to be maintained within the 
community.  
 
 Community staff have expressed enthusiasm for the 
model, but frustration at the lack of increase in funding, 
                                                             
16 MBRN (2018). Bay Health & Care Partners: Respiratory Case for Change Proposal  
17 The Respiratory Case for Change Proposal cites all ICCs across Morecambe, Lancaster and Carnforth as 
having established respiratory clinics. It should be noted that this evaluation was only able to access 
qualitative data from Queen’s Square and Lancaster ICCs (see above, Section 2.3). 
18 MBRN (2018). Bay Health & Care Partners: Respiratory Case for Change Proposal, p.4 
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and the subsequent impact on their time. 
 
 Plans to increase capacity for rapid response and 
pulmonary rehab, and to develop a hospital at home 
service, which would include oxygen therapy, IV 
antibiotics or nebulised therapy, are proposed but not yet 
considered at the time of writing this report. 
 
Figure 2 Key Changes Introduced by the MBRN 
 
 
Due to delays with the roll-out of Bundle 2, it has been reported by participants that “nothing has 
dramatically changed on the ground” (SS-17-PR-H-21082018) since the Stage 2 Early Findings Report, 
where a more detailed exposition of the changes implemented by the MBRN model can be 
found. The following section of this report summarises the key mechanisms of change, identifies 
any differences across sites, and presents patient perceptions of change to their care. 
 
 
3.2.1 Model Design and Leadership 
 The 12 Month Report highlighted that leadership was a key active ingredient in the 
delivery of a new model of care. However, it also pointed to a noticeable gap between 
localised initiatives, based on an ethos of collective leadership, and strategic direction, 
based on more of a top-down approach. The result of this was that successful local 
initiatives struggled to translate into wider and more significant changes to the health 
economy. 
 
 It is clear from participant contributions that the MBRN leadership model has offered an 
alternative model of leadership, which has helped to move this model of care beyond the 
impasse found in many of the other vanguard initiatives.  
 
 The process of change was led by a small group who were passionate about improving 
the quality of care. The group operated relatively autonomously from formal BCT 
processes (compared to previous change initiatives) and instead engaged with those 
involved in respiratory care. This resulted in a clear and evidence-based design structure, 
following an ethos of integrated care provision. 
 
 Key to this approach is an understanding of the expertise held by different specialities 
and roles across secondary, primary and community care services, and that better care is 
dependent on joining that expertise up. Interviews with other staff involved in the bundle 
1 roll out suggested that the process was one of iterative development, based on 
dialogue and valuing contributions from all areas. 
 
“It made you feel valuable, that we mattered as a [*name] service, that they valued 
our input. That gives you a warm, fuzzy feeling to start with. It makes you feel 
valued.” (INT080) 
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 Alongside this, observations of MDTs suggested GP teams appear open and willing to 
learn from the MDT process, asking what one attendee described as “learning 
questions”, and presenting a case for “learning purposes”. Within one MDT discussion, 
the consultant appeared open about the difficulty in interpreting some test results and 
scans, reinforcing the ethos of a learning culture. 
 
 The available evidence indicates that the MBRN has succeeded in engaging respiratory 
staff from the hospital, the ICCs and community services in the bundle 1 roll out. This is of 
particular note given the negative contexts surrounding attempts to re-model care, 
described in Section 3.1.3 above.  
 
 Conversely, the risk of such a model is that it depends heavily on the character of those 
driving the change. This may have implications for the wider roll-out of the model. 
Variables to consider are discussed below in Section 3.5. 
 
 Participants also voiced some concerns about the speed at which the model was 
implemented, due to the availability of funding. 
 
 Some patients with a respiratory condition have been referred to the lead GP in their 
practice. This has led to a review of their diagnosis, medication and/or a discussion of 
their case at the MDT. Patient interview data indicates that patients are reassured by 
their referral to a GP with expertise on respiratory and that they have increased 
confidence in their ability to treat their condition. Some patients reported feeling that 
their concerns were finally “being listened to.”  
 
“I think that as soon as somebody seems to be on your side and here to help you, 
then you feel that you are not alone.  But when somebody basically gives you the 
impression that they don't care one way or the other, it doesn't really do a right lot 
for your confidence, does it?” (INT074) 
 
 
3.2.2 Improved Ways of Working 
 Participants cited improved communication, facilitated by the MDTs, as a key 
improvement in their ways of working. 
 
 As part of the MBRN’s development over its first 12 months, EMiS templates have been 
developed for respiratory care. It should be noted that poor data quality has been a 
recurring disabling theme for change across both stages of the NCM evaluation. While 
only recently introduced, this template should address a number of these issues, 
including contextual problems with the amount of data the QOF requires (see above, 
3.1.5), as well as standardising coding across GP practices. 
 
 The formation of ICC respiratory teams and the MDTs have been critical components in 
bringing together expertise from primary, secondary and community care to deliver a 
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more joined up and time efficient approach to respiratory care. In doing so, it has broken 
down barriers to joined up working: 
 
“Bringing people together as a network, which was always one of our key aims. 
Prior to this, a lot of those people in the room didn't know each other.” (INT095) 
 
 The interview data suggests that the MDT discussions are removing the barriers to 
communication that previously existed between primary, secondary and some 
community care services. Although MDTs have ‘core’ members, they appear to be open 
to anyone who has knowledge of the patients being discussed.  
 
 Based on observation data collected from three MDTs (see Section 2.3), it was noted that 
much of the discussions in the MDT are highly medicalised and focus upon diagnosis and 
medication. However, there was also some discussion of the social, economic or cultural 
factors that affect the management of disease. In particular, the more intimate 
knowledge of the patient held by the ICC team presenting a case provides information 
that can be used by the consultant to inform the diagnosis or treatment plan. For 
example: known allergens in the house (e.g. pets), smoking behaviour, extent of their 
breathlessness (e.g. how do they present at appointments), and so on. 
 
 In two of the observed MDTs, it was acknowledged that the discussions were highly 
medical and complex. The chair suggested that his reflected the early stages of the MDT, 
where much of the focus was on diagnosing patients. It was expected that more 
management discussions would develop over time. It was also proposed that GPs, and 
other interested parties, meet for one hour before the official start of the MDT to discuss 
diagnosis. 
 
 Observation data collected from three MDTs suggest that there are some differences in 
operation between North Lancs and Barrow. This was reinforced in interview data with 
participants who attended both. One difference was available technology in the meeting 
location: in North Lancs MDTs, CT scans can be displayed on a large screen, allowing the 
consultant to explain what is on a scan and how it should be interpreted, therefore 
facilitating learning more easily than a similar activity in the Barrow MDT, which lacked a 
larger screen on that particular day. 
 
 Another key difference is the presence of admin support:  
 
“So the difference there is that the clinicians in Lancashire have got somebody 
behind the scenes, following through on all the actions. When the clinician says, ‘Can 
you refer this patient to so and so’, in Lancashire, that is done by the admin person 
or it is facilitated. Whereas in Barrow, somebody has got to remember to do it when 
they go back to their desk.” (INT095) 
 
 
3.2.3 Use, Type and Availability of Resources 
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 A number of components of the care model that are making a difference involve well-
targeted, locally relevant and accessible activities that encourage patients/citizens to 
socialise with their peers and/or engage with self-care, whilst gaining appropriately 
targeted help and support from various healthcare professionals. For example, an 
Airways Café in Carnforth was cited as a good example of a low-cost, high-effect activity: 
 
“…the quality of life for those patients has really gone up, since that café. Feelings 
of well-being, less exacerbations. It had a double strand. One was information and 
social interaction, but we also saw them in clinic at the same time and did their 
observations.” (INT084) 
 
 A key enabler for the MBRN was seen as clinician or managerial buy-in into the new 
model. Where managers were supportive of the new model, clinicians reported being 
able to adapt their working day to accommodate the additional workload. In contrast, a 
few interviewees observed that there was a lack of managerial buy-in in some bundle 1 
ICCs. Given that funding was present in all of these ICCs, this suggests that “buy-in” refers 
to a commitment to the ethos of the model, as well as financial capacity. However, lack of 
qualitative data from these ICCs prevents firmer findings being presented.  
 
 A more disabling aspect of the changes was raised in the qualitative data through 
suggestions that the involvement of GPs in the new respiratory teams places increased 
pressure on practices, especially where there are GP shortages. Likewise, releasing 
consultant time from secondary care presented difficulties. The CCG were referenced as 
being particularly supportive of making adjustments to working hours, but the challenges 
remained: 
 
“One of the main challenges is finding time really, because everyone who is working 
in the system is pretty much working full time anyway, so how do you mobilise time 
to bridge where other systems start effectively to give you your time back?  Initially, 
everyone had to take more time -- for example, the Multi-Disciplinary Team meeting 
runs on […] my half-day, essentially, I don't work that day, so coming on that day to 
be able to do it.”  (INT083) 
 
“Without the investment from Vanguard, you're a little bit hamstrung into 
providing – it’s how much extra our teams can provide, without the backfill.  If we 
don't backfill [*consultant], for example, it leaves me with a ward that is uncovered, 
which means that I can't put him in the community and then test the actual 
outcome of our theory.  […]  Because as soon as you switch on a pilot, there will be 
a lag time from reducing some of that demand coming through the hospital, and we 
need to dual run for a period of time until that critical mass is achieved.” (INT093) 
 
 Participants also expressed frustration that funding decisions had been delayed, and that 
the community “leg” of the model was yet to be fully implemented. 
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 However, because the number of GP referrals has reduced following the formation of the 
ICC respiratory teams and MDTs, participants have reported that secondary care now has 
more capacity to manage complex asthma and COPD cases who were previously 
transferred to either Manchester or Preston. This directly addresses some of the 
contextual disablers for improving respiratory care discussed above in Section 3.1.1. 
 
 
3.3 What is causing the outcomes demonstrated in particular elements of the 
programme, systems, patients or staff? What expected or unexpected impact is the 
new care model having on patient outcomes and experience, the health of the local 
population and the way in which resources are used in the local health system? 
 
 
The Stage 2 Early Findings report identified and detailed six outcomes of the model after the first 
six months of its implementation. These were: 
 Improved Diagnosis; 
 Improved Care management; 
 Reducing secondary care activity (reducing outpatient appointments and reducing 
non-elective attendances; 
 Increased Productivity; 
 Improved Staff experience; and 
 Improved Patient experience.19 
 
This section uses patient and staff interviews to develop these initial findings further, in four 
areas: Reductions in Referrals and Secondary Care Activity; Upskilling Staff; Improved Disease 
Management and Diagnosis; and Increased Confidence. 
 
 
3.3.1 Reduction in Referrals and Secondary Care Activity 
 The formation of the MDTs allow the ICC respiratory teams to discuss cases in the MDT 
meetings rather than make a new referral to an outpatient clinic. This results in a 
reduction in new referrals to secondary care. The quantitative data to support this is 
listed below, in Section 3.4.4.  
 
 As with the 12 Month Report, there is always a need to treat higher-level outcome figures 
with some caveats. In this case, the following points need to be considered:  
 
                                                             
19 See HASCE (2018), Local Evaluation of Morecambe Bay PACS Vanguard: Stage 2 Early Findings Report, 
Section 3.5 
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 The MBRN was implemented over a short space of time, and observations of the 
MDTs in North Lancs noted that delivery was an on-going and iterative process. 
As such, a longer view is needed to assess its true effect on patient outcomes. 
 
 At the beginning of the model’s implementation, there was no code for patients 
using the MDT. As a result, it has not been possible to compare patient pathways 
over a significant amount of time to compare outcomes. The 12 Month Report 
recommended that changes introduced by NCMs needs to be assessed from a 
patient level as well as a general level: that is to say, following specific cohorts of 
patients who have been through the MDT route, and comparing these to patients 
who have not. This has not been possible in the time of this report writing, 
however. 
 
 The primary need for this is due to the number of extant variables that affect 
referral rates in respiratory, such as winter crises. 
 
 It should also be noted that while reducing referral rates is an objective of the 
MBRN, reviews of diagnosis may not necessarily always lead to moving patients 
away from hospital, at least in the short term. 
 
 A number of patient interviewees welcomed the changes as they reduced the number of 
hospital visits, which was perceived to be beneficial for both patients and the economy.  
However, others, who were generally satisfied with standards of care prior to the 
implementation of the new model, felt that the quality of care and their experience of it 
had remained the same.  
 
 In the absence of an investment in community services, it is unclear how much scope 
there is for the MBRN’s model of respiratory care to address the social, economic and 
environmental stressors that affect how patients respond to and manage their condition. 
As the following quote from one participant illustrates, support may be required with 
housing and financial issues before a patient is able to effectively self-manage their 
condition.  
 
“Since I had (a separate health problem) and the bad do with the COPD, I've come 
out of work.  I've had no help.  I haven't had a penny of help in two years. […] I was 
just getting there and then the roof broke, so I've had a new roof put on and then 
it's square one.  I'll probably be dead before I've got enough to get central heating.  
But there should be something, there should be someone to be able to come out 
and help you like that.”   (INT073) 
 This points to the variety of factors which affect the ways in which change is 
implemented, and that may not be immediately visible in higher-level outcome figures.  
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3.3.2 Upskilling Staff 
 Staff interviewees reported learning from the MDTs, in particular through the transfer of 
knowledge from the consultant to primary care practitioners. Although there are some 
differences in the way that the Barrow and North Lancs MDT operate, participants 
reported that both facilitated learning.  
 
 It is worth noting that evidence of this outcome is provided by interviewees’ perceptions 
only, as there was no formal before and after measurement of knowledge and skills. It 
also needs to be remembered that leads from some practices did not engage with the 
evaluation, so the reach of upskilling is not currently evidenced. However, other 
measures do point to increased skills in managing respiratory cases. In particular:  
 
 the speed at which patient cases are dealt with during MDTs;  
 the time devoted to explanations of clinical decision-making within MDTs; and  
 patients reporting of satisfaction that their condition has been dealt with 
appropriately.  
 
 Following the referral to the lead GP, patients felt that their health concerns were being 
increasingly listened to and recognised. For example, one interviewee, who felt that their 
concerns had been previously dismissed, was reassured by the lead GPs confirmation that 
“something was going on” with their chest and that there was a need for further 
investigation. Similarly, another interviewee described how their referral to the lead GP 
had led to investigation:  
 
“I've been talking about this in my throat for nearly two years and [*lead GP for 
respiratory] picked up on it and said well, we'll try it. […] Well, the previous care 
was all right, but he's a specialist, whereas the doctors I've been seeing down at 
[*GP Practice], they're not specialists in that field.  So, it's antibiotics, antibiotics.  
He's come with a different angle and he's made things better. (INT077) 
 
 
3.3.3 Improved Disease Management and Diagnosis 
 
Clinical Management 
 The increased communication between primary, community and secondary care services 
facilitated by the MDTs was described as creating opportunities for staff to collectively 
learn, plan and provide patient care. Most interviewees expected the increased 
communication between clinicians and the upskilling of staff to improve the accuracy and 
quality of diagnosis. 
 
 This was supported by interviews with patients, who described how the lead GP had 
arranged for diagnostic tests, reviewed medications or referred them to pulmonary 
rehabilitation. 
28 
 
 
“When I went in to see him, he could see on the record that I'd had asthma.  He did 
listening to the chest and all the rest of it and he recognised that it was pretty bad 
asthma, as well.  He said, "Look, we need to run you through quite a lot of tests just 
to establish how bad your asthma is." And if there's anything else, an underlying 
cause.” (INT078) 
 
“Since I got put on to [*lead GP for respiratory] I've got a blood test, x-rays. Last few 
weeks I had a CT scan and I'm down for the breathing… course. That's a 24 week 
wait, but I'm down on it. That's in a matter of a couple of weeks, so I can't complain, 
I think it's all right, yes.” (INT071) 
 
 Medication reviews led to a change in the prescriptions of some patients and some felt 
that their condition had already began to improve as a result. Others reported the 
benefits of having their diagnosis reviewed and possibly changed. 
 
“I had a particularly bad winter last winter and it was them that -- I saw [*GP lead 
for respiratory] and I had my medication reviewed and received a different inhaler 
which helped enormously.” (INT076) 
 
“According to my wife I'm not snoring as much.  So, it does seem to have helped, 
which is real boon…” (INT077) 
 
Self-Management 
 Understanding of diagnosis and treatment is needed to enable patients to manage their 
condition more effectively. There was some evidence that patients were being given 
information by GP surgeries to support self-management. For example, one patient 
reported that they had received a long letter from the lead respiratory GP in their practice 
that explained her treatment and the next steps and another described how they had 
benefited from advice on breathing techniques.  
 
“As long as I'm given enough information from the doctor or the Practice Nurse 
about the symptom and how it can affect and what I can do, I am much happier that 
way.” (INT066) 
 
 Pulmonary rehabilitation provides a more comprehensive programme of support to 
those that are breathless and helps patients to better manage their condition and their 
symptoms. Although several patients had been referred to pulmonary rehabilitation, they 
reported waiting lists of up to 24 weeks. Although one interviewee who had completed 
pulmonary rehabilitation was indifferent to its value (they felt that it had not provided 
any new information), others found the course helpful and described how it had provided 
the techniques needed to manage exacerbations. Another interviewee with severe 
symptoms described how they used the breathing techniques developed through both 
29 
 
pulmonary rehabilitation and a programme run at the local hospice to stay as well as they 
can: 
 
Even when I'm ill, I'll still try and do a little bit, even if it's only a little bit of the 
exercise on each one.  They did actually give me the motivation.  Then going up to 
the hospice, that made it even better again. (INT072) 
 
 Patient responses indicated that the success of the model involved a careful balancing of 
providing patients with a sense of control over their breathlessness, managing potential 
anxiety, and providing meaningful information during contact time. Patients frequently 
noted the frustration, prior to the MBRN model, of being subjected to testing without full 
explanation or not receiving follow-ups to test results, which provided a barrier to 
improving their self-care. 
  
 Meaningful information is based on patient-centred approaches, as not all patients 
understand the information given to them.  Test results in particular appear difficult for 
some to interpret and a lack of understanding of their implications can create anxiety:   
 
There's lots of diagrams and charts and tables on the computer, but I'm hopeless 
with things like that.  I just know how it feels. (INT068) 
 
 
3.3.4 Increased Confidence 
 
In Patients 
 Patient interviews reported being reassured by the perceived specialist knowledge held 
by the lead GP for respiratory in their practice. Increased trust and confidence in a GP or 
Practice Nurse’s ability to manage care also emerged as being an important outcome. 
While many reported that they had always trusted their knowledge, the more specialised 
knowledge held by the lead GP appears to be increasing the confidence of some patients: 
 
“He certainly gave me confidence that he knew what he was talking 
about.”(INT068) 
 This, in turn, increased the patient’s capacity for self-care: 
 
“I'm a little more confident now than I was, than I have been.” (INT068) 
 Trust in clinicians providing care, and a sense that there was continuity, were valued 
factors in the way care was being provided. In addition to increased confidence in the 
care being provided by their GP surgery, one interviewee also felt that the management 
of their care was providing the doctor-patient continuity that had been previously absent: 
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Much better than anything that I was being offered at the hospital. I mean, you go 
to the hospital and you know exactly what's going to happen.  You go and get 
weighed, you go on the breathing machine, you go into see either the registrar or 
one of their other people.  They all tell you something different and scribble 
something down and sometimes don't even make eye contact with you.  Then they 
say, "We'll see you in three months." At least somebody knows my name, they know 
who I am and they are talking to me.  (INT074) 
 
 Some interviewees reported that they now request the GP lead by name when making an 
appointment at their practice. For one patient, this meant a longer journey to the surgery 
at which an appointment for the GP lead was available: 
 
“That's a difference.  Not to be able to nip for five minutes down the road.  I had to 
walk for 40 minutes instead. It's because I insisted on seeing him…  He certainly 
gave me confidence that he knew what he was talking about.” (INT068) 
 
In Staff 
 Staff also appear to have more trust or confidence in the system following the 
establishment of the MBRN. Increased communication, clear care pathways and 
improved reporting contributed to a theme that one participant described as “we’ve got 
your back.” Both staff and patients having increased confidence that patients aren’t 
falling between the gaps in primary and secondary care, with the MDTs being the main 
vehicle for integrating care across organisations. 
 
 A key example of this was observed in an MDT meeting, where, in addition to ICC teams 
presenting patients, the consultant and physios also flagged cases of concern. This 
ensured multiple perspectives were brought to cases, to ensure more complex areas of 
diagnosis and/or treatment were not missed. 
 
 One participant described how trust had been increased between clinicians and that 
consultants were now comfortable with patients being managed in the community: 
 
“With clinicians, once you know somebody you can start to trust them, and once 
you trust them you can then work with them and refer to them. I think particularly 
for the consultants, letting go of a patient was difficult if they didn't know the GP or 
nurse in the practice. They wanted to hang onto them. Now they are much more 
amenable to letting go of the patient and referring them back to the practice.” 
(INT095) 
 The MBRN has invested time and resources into upskilling staff and establishing channels 
of communication across disciplines and areas of working. This has led to staff feeling 
better supported and more confident in their roles:   
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“In a very short space of time, practices are now empowered and are confident to 
make their own decisions and assessments about patients that were previously sent 
into hospital.” (INT091) 
 
3.4 What is the change in resource use and cost for the specific interventions that 
encompass the new care models programme locally? How are vanguards performing 
against their expectations and how can the care model be improved? What are the 
unintended costs and consequences (positive or negative) associated with the new 
models of care on the local health economy and beyond?  
 
 
3.4.1 Methodology 
 
This section of the report therefore focuses on the resources used and projected for the MBRN, 
which requires a separate methodology to the qualitative approach guiding the bulk of the 
evaluation work.  
 
In this case, the question of change in resource use and cost follows the structure suggested in 
the document Cost Evaluation of Interventions in the New Care Models Programme,20 which has 
been produced as a guideline by the Operational Research and Evaluation Unit at NHS England to 
explore the changes in resources use and costs resulting from the implementation of 
interventions within the New Care Models (NCM) programme. This methodology provides a clear 
path for cost evaluation at the level of a clearly defined intervention. This makes the task of 
clearly defining a comparator or counterfactual scenario easier, and therefore the cost 
comparisons more robust. In addition, the model is designed to provide a clearer indication of 
the transferability of particular interventions to other local areas.  
 
The guideline document21 identifies two areas as potentially challenging a detailed cost 
evaluation which are of particular relevance to this evaluation: 
 
(1) Availability of robust outcomes data:  
Cost effectiveness analyses can only take place if data on the effectiveness of 
interventions is available, which can then be combined with data from a cost evaluation. 
 
 Whilst this cost evaluation is produced on the grounds of evidence-based 
quantitative data, a significant challenge has been obtaining real-time data on 
both costings and patient numbers related to the MBRN. The most recent report 
from the MBRN Steering Group to the CCG Executive from August 2018 clearly 
indicates that the level of quantitative data available for the cost evaluation of 
                                                             
20 Operational Research and Evaluation Unit, NHS England (2018). Cost evaluation of Interventions in the 
New Care Models Programme. 
21 Ibid. 
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the MBRN is not as advanced as was predicted by this point in time. Because the 
MBRN data dashboard is not yet live, this evaluation is still based mostly on 
projected figures from earlier in the year rather than real-time data. This will also 
have some implications for the evaluation of potential cost savings through the 
implementation of the MBRN.  
 
(2) Maturity of the interventions in question:  
Because the MBRN is very new and only partially implemented, this makes it extremely 
difficult to arrive at a robust cost evaluation, and consequently a cost effectiveness 
analysis. 
 
 While outcomes data does exist on the level of acute baseline respiratory data 
and primary care baseline respiratory data for the MBRN, baseline respiratory 
data from community services are essentially non-existent, as these services are 
not yet set up. These services delivered by community teams, however, form the 
vital third pillar besides acute and primary care, on which the principle of the 
MBRN rests.  
 
 In addition, as the evaluation has documented in previous reports, the 
implementation of a new model of care takes time: establishing participation and 
‘buy-in’ from clinicians, and developing a model iteratively in order to best suit the 
local contexts, all need to be taken into consideration when viewing the 
quantitative figures used in this analysis. 
 
With these caveats in place, the next section will detail the parameters contributing to the cost 
analysis of the MBRN.   
 
 
Decision Problem 
 
The methodological approach to investigating the resource use in any context depends on what 
decisions we expect this information to inform. This so-called ‘decision problem’ is split into two 
processes:  
 
(1) Identify, measure, and value the resources used in implementing the MBRN model in 
sufficient detail to allow other areas of the NHS to replicate the intervention if they 
decide to do so.   
 
(2) Identify, measure, and value the change in resources used in implementing the MBRN 
model in sufficient detail to inform decisions regarding its cost-effectiveness. 
 
While process (1) can be seen as a stand-alone implementation analysis, in order to understand an 
intervention in all financial details, it is also a prerequisite step for process (2), which is concerned 
with change in resources and therefore requires establishing the costs associated with a 
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counterfactual scenario. The counterfactual scenario, however, is also highly dependent on the 
availability of data pertaining to the period before the implementation of a new service.  
 
As noted previously, the MBRN model was built around three “bundles”:  
1. 1st wave ICCs (Barrow Town, Queen Square, Lancaster, Morecambe and Carnforth ICCs) 
2. 2nd wave ICCs (Kendal, East, Alfred Barrow, Millom & Duddon, Ulverston & Dalton and 
South Lakes) 
3. Reduction in specialist respiratory capacity and acute bed capacity 
 
The MBRN aims to manage patients with respiratory disease with two core changes to the 
current way of working:  integrated community clinics (MDT with GPs, respiratory consultants, 
practice and specialist nurses) and Community Services (Hospital at Home, pulmonary rehab etc.) 
to support earlier discharge and admission avoidance. Each Primary Care Network (PCN) will have 
a respiratory team led by a GP and linked respiratory physician and nurse specialist. The GP lead 
has overall responsibility for delivering the objectives, triaging referrals from ICC, educating 
practice staff, and attending the monthly community MDT clinic.  
 
The main KPIs for this model were:  
 Reduce Non-Elective admissions by 20% by the end of 2018. 
 Reduce Out-Patient attendances by 50% by the end of 2018. 
 Reduce Emergency Bed Days by 25% by the end of 2018. 
 
As mentioned in Section 1.4, only one part of Bundle 1 is operative at present. To date, the main 
focus of the MBRN implementation has been in the General Practices that are aligned to the two 
MDT meetings. The involvement of lead GPs in all practices commenced in October with 
leadership provided by the MBRN lead clinicians to the two MDT areas: 
 
 Lancaster / Morecambe / Carnforth MDT: Lancaster Medical Practice, Queen 
Square Medical Practice, Bay Medical Practice, Ash Trees Medical Practice 
 
 Barrow MDT: Duke Street Medical Practice, Bridgegate Medical Practice, Burnett 
Edgar Medical Practice, Norwood Medical Practice 
 
While integrated community clinics (MDTs and additional primary care clinics) are implemented, 
Community Services are not yet running. The scope of this evaluation therefore focuses on 
Bundle 1 activities, but includes projections about the costs of the Community Service provisions. 
 
 
Perspective 
 
The perspective of a study refers to the scope of the cost evaluation and in turn which costs (and 
benefits) are accounted for. In the case of the MBRN costs and benefits that are relevant to NHS 
decision making are deemed to be the first priority for this economic evaluation. Broader effects 
on the health economy, including benefits to patients (for example, reduced journeys to hospital) 
are not covered in this area of the analysis. 
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Time Horizon 
 
The time horizon refers to the time period over which the change in costs and benefits is 
investigated. The time horizon for this study is October 2017, when Bundle 1 started to be 
formally implemented, until present (September 2018).  
 
 
3.4.2 Identification, Measurement and Valuation of MBRN interventions 
 
The following questions22 have been used as guidelines to establishing the elements that 
contribute to the costs of delivering the MBRN: 
 
a) Was there a significant stage of implementation of the service, prior to it being (fully) 
established? If so, what did this involve? 
The set-up cost for Bundle 1 was calculated at £7k. This included training for GPs and nurses.  
 
b) What are the key steps in the process of delivering this service (e.g. who is involved, 
preparation for MDT, MDT meeting, post MDT actions)? 
This can be broken down into MDTs, Other Primary Care Elements, and Secondary Care. A 
breakdown of involvement in the delivery is detailed here: 
 
MDTs 
 
Participants 
While participation at an MDT may vary, the attendance list an observed North Lancashire MDT 
meeting provides an indicator of typical participants: 
 Lead GP for Queen Square (also MBRN lead) 
 Lead GP for Lancaster Medical Practice 
 Lead GP for Bay Medical Practice 
 Lead GP for Carnforth 
 A practice nurse from Lancaster Medical Practice  
 A practice nurse from Bay Medical Practice 
 A pharmacist from Lancaster Medical Practice  
 RLI respiratory consultants 
 Respiratory Advanced Nurse Practitioner 
 Physiotherapist 
 Specialist respiratory link (head of pulmonary rehab) 
 Senior project manager for MBRN 
 
 
                                                             
22 Ibid. 
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Patient Identification 
Since March 2018, the North Lancs MDT has dedicated admin support. The admin support officer 
circulates an agenda to MDT members in advance of the meeting and invites them to add the 
NHS numbers for the patients to be reviewed. From observations in the MDT meetings, we know 
that the large majority of patients are presented by GPs, with a smaller number being presented 
by practice nurses. Additionally, the respiratory consultant also occasionally raises queries about 
patients they have recently seen in a clinic or who have an appointment at a future clinic. 
Occasionally, the physiotherapist may also present a patient. Updated pathways for the different 
respiratory conditions under the remit of the MBRN clearly indicate when a patient should be 
presented to the MDT. 
 
The MDTs in Barrow currently do not have dedicated admin support. This will have a knock-on 
effect on clinicians time, as administrative tasks completed during the North Lancs meetings will 
need to be completed after the Barrow meetings. 
 
Preparation for MDT meeting 
The admin support arranges room bookings. As described above, they circulate the agenda in 
advance and invite MDT members to add patients to be reviewed. 
 
MDT meeting 
The meetings take place once a month and two hours are allocated to each one. There are plans 
for an additional ‘optional’ hour to be included in the future to allow for more technical 
discussion of diagnoses. The admin support takes minutes at these meetings. 
 
Post MDT meeting action 
Where a patient has been discussed at an MDT, this is now recorded on their Lorenzo record (as 
of June). Other actions would depend on the agreed treatment/diagnosis plan for each patient. 
For example, further tests, a referral to physio or pulmonary rehabilitation, presentation at x-ray 
meetings, smoking cessation advice, different medication or a referral to a consultant’s clinic. 
 
 
Other Primary Care Elements 
 
GP lead and additional respiratory clinics 
A GP lead has been established in each of the 5 bundle 1 ICCs, these are Barrow, Carnforth, the 
Bay, Queen Square and Lancaster. Each of these ICCs were expected to set up new respiratory 
clinics, but the evaluation has not collected evidence on this. 
 
Those involved in each ICC respiratory team will differ across the bundle 1 areas. For example, in 
Lancaster it includes a lead GP, two practice nurses and a pharmacist. A partner was also involved 
in the initial set up but does not attend their new clinics or the MDT. We do not have a similar 
depth of data for the other bundle 1 ICCs. 
 
Role Changes 
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The majority of roles have not changed but the formation of the MDT and ICC clinics has led to 
their inclusion in these new activities. The roles of the two people leading the new model’s 
delivery have changed though and they now receive additional vanguard funding to reflect their 
involvement in it. 
 
Training 
GP leads received a full day’s training with a respiratory consultant. Nurses attended also 
attended a day’s training. 
 
Additional work or taken from other activities 
This varies within the different practices and ICCs. For example, there are two respiratory clinics 
in Lancaster. One is run by a GP and nurse, and the other by a pharmacist and nurse. The nurses’ 
time is backfilled (the practice pay other practice nurses to work additional hours to cover the 
respiratory nurses’ time in the clinic). However, there is no backfill for the GP. The 
physiotherapist and specialist respiratory link’s time is additional. The MBRN pay them to attend 
the MDT on their day off.  
 
 
Secondary Care Elements 
 
Contributions from secondary care come in the form of MDT participation of respiratory 
consultants and nurse practitioners. At the same time, however, the biggest benefits of the 
MBRN are expected to be a significant reduction in UHMB respiratory outpatient as well as 
inpatient activity.    
 
 
3.4.3 Funding Calculations 
 
In August 2017, the Better Care Together Delivery Group approved the proposal to commence 
Bundle 1 as a pilot to the end of 2017/18 to be funded from non-recurrent vanguard monies. The 
investment ask was £311k23.  
 
Cost of providing Bundle 1 in 2017-18 
GP population payment £221k 
Clinical Leadership & MDT £23k 
Community team/nurses £35k 
Set up £7k 
Community equipment £25k 
TOTAL £311k 
Table 3: Investment requirement for Bundle 1 
 
                                                             
23 BHCP (2016). Morecambe Bay Respiratory Network – ROI progress update. 
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The GP population payment in the original service specification was based on an estimate of £3 
per registered patient paid from November 2018, irrespective of disease prevalence. This yielded 
the following cost calculation for Bundle 1 ICCs: 
 
ICC List Size  Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 2017-18 
Barrow Town 33,698 £8,425 £8,425 £8,425 £8,425 £8,425 £42,123 
Carnforth 15,058 £3,765 £3,765 £3,765 £3,765 £3,765 £18,823 
Morecambe 60,863 £15,216 £15,216 £15,216 £15,216 £15,216 £76,079 
Lancaster City 52,942 £13,236 £13,236 £13,236 £13,236 £13,236 £66,178 
Queen Square 14,045 £3,511 £3,511 £3,511 £3,511 £3,511 £17,556 
TOTAL 176,606 £44,152 £44,152 £44,152 £44,152 £44,152 £220,758 
Implementation coverage of 
Bundle 1 (based on total patient 
population of 342,530) 51.56% 51.56% 51.56% 51.56% 51.56%   
Table 4: GP population payment calculation 
 
Costs of clinical leadership and MDT and community services were estimates. As more detailed 
information about the requirements for these is now available, a more comprehensive cost 
calculation is presented in the next section. 
 
Project development support from Morecambe Bay CCG, UHMB, Cumbria Partnership 
Foundation Trust (CPFT) & BTH were not included in these calculations. Moreover, from the same 
document we know that £180k of non-recurrent enablement funding was not included in the 
original MBRN proposal considered by the  Delivery Group, as this was being funded through the 
non-recurrent support to General Practices bid to NHS England. This essential funding, however, 
has been lost and will require replacing. 
 
From the interviews conducted for this evaluation, participants were asked about how much 
time they spent on the respiratory care before and after the MBRN was introduced. This 
information was not provided as an objective measure, but rather to reflect the immediately to-
hand knowledge of time spent on the network. It has become clear that information on which 
positions are funded from which source is incomplete, as the following table shows: 
 
Position 
Time Spent on 
Respiratory Care 
after MBRN model 
introduced 
Time Spent on 
Respiratory 
Care before 
MBRN model 
introduced 
Difference in 
time spent on 
respiratory 
care  
How time is 
spent (e.g. 
MDTs, ICC 
clinics) 
How time 
spent on 
MBRN 
model is 
funded 
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Position 
Time Spent on 
Respiratory Care 
after MBRN model 
introduced 
Time Spent on 
Respiratory 
Care before 
MBRN model 
introduced 
Difference in 
time spent on 
respiratory 
care  
How time is 
spent (e.g. 
MDTs, ICC 
clinics) 
How time 
spent on 
MBRN 
model is 
funded 
GP and 
Clinical Lead, 
Respiratory 
7.5 per week24     
Planning, 
MDTs, 
meetings, and 
leading on the 
project 
Vanguard 
until April 
2018 
Nurse 
Practitioner 
2 hours per week 
plus 1 extra unpaid 
hour (this is 
additional to their 
'normal' role. They 
attend the MDT on 
their day off after 
the model offered 
to pay for their 
additional hours). 
    
MDTs and prep 
for them. 
Not sure 
Practice 
Nurse  
6.5 to 7.5 per week Hard to say Hard to say 
MDTs, Clinics, 
and admin. 
Not sure 
Respiratory 
Consultant, 
UHMBT 
2 sessions per 
month 
No 
increase/decrea
se 
No 
increase/decr
ease 
Assisting the 
network, MDTs 
Not 
Vanguard 
funded 
Physio and 
Respiratory 
Link  
2 hours per month       Vanguard 
Specialist 
Respiratory 
Link  
2 to 2.5 days per 
week amongst 
staff at the 
Practice 
  
Increased 
time spent on 
respiratory 
  Federation 
Divisional 
General 
Manager 
Medicine 
2 hours per week 
in her 
management role 
 No change 
Providing 
operational 
support 
Part of day 
job so 
funded by 
UHMB 
Project 
Manager 
Half a day per 
week 
    
Supporting the 
project 
100% 
vanguard 
funded 
Table 5: Workload and funding information from interviews 
 
Due to the incompleteness of data and the disparity in working models (e.g. whether time is 
additional to workload or backfilled, which varies from practice to practice) it is extremely 
difficult to calculate actual resource use and the proportion of funding from vanguard monies. As 
                                                             
24 N.B. only 3.5 hours of these hours spent on MBRN are funded. It is expected that once the network is 
better established and has been running for a while, 3.5 hours are realistic. This also depends, however, on 
community services being fully operational.  
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can be seen from the table, precise information on change in working time/activities before and 
after the MBRN implementation is lacking for all positions.  
 
It is therefore deemed impossible to base this evaluation on a counterfactual scenario. 
 
The next sections, therefore, attempt to arrive at more detailed costing calculations, which will 
focus the investigation on the evaluation of resource use and the cost of delivery of the MBRN. 
Early indications of impact on healthcare utilisation will also be taken into consideration, which 
will provide insights towards a cost/benefits analysis.  
 
 
Cost Calculation: General Practice 
 
At present, funding allocated to General Practice is based on an allocation of £3 per patient on 
the practice register list, irrespective of disease prevalence. This initial £3 per registered patient 
investment is intended to be replaced eventually by a more accurate cost of service value derived 
from actual workloads and the individual practice prevalence of respiratory disease. As the MBRN 
service specification is being continually developed, individual elements have been identified. 
Estimates of actual workloads have been established from service specification data and 
interviews and costs were calculated using PSSRU25 data, as shown in the following table: 
 
Component Time and Value Estimates Cost Notes 
GP Sessional 
Time 
3.5 hours at £120.3026 for 42 
weeks27  
for every 15,000 patients 
on the practice list 
£17,684  
(per 15,000 list 
patients) 
Clinician time to lead the ICC team, 
see new referrals, support other 
staff and attend MDTs 
GP CPD 
8 hours at £120.30  
 
£962 
(per 15,000 list 
patients) 
Day release for a GP to attend one 
MBRN update course a year 
Nurse time28 
3 hours at £41.7029 for 42 
weeks30 
plus opportunity costs 
£9,633 
(per 15,000 list 
patients) 
Nurse time is evidenced from 
interviews. Opportunity cost is 
calculated as partial backfill of half 
                                                             
25 Curtis, L. & Burns, A. (2017) Unit Costs of Health and Social Care 2017. Personal Social Services Research 
Unit (PSSRU). University of Kent, Canterbury 
26 PSSRU 2017 unit cost per hour of GP activity (£127), taking into account the scaled Market Force Factor 
for use in reference costs for UHMB Trust of 0.9471.  
27 Average GP working time is calculated in the PSSRU 2017 report as 41.4h/week, 42 weeks per year. 
28 This is based on the information of additional nurse time from the table above 
29 PSSRU 2017 unit cost per hour of Band 6 Nurse activity (£44), taking into account the scaled Market 
Force Factor for use in reference costs for UHMB Trust of 0.9471 
30 Average Nurse working time is calculated in the PSSRU 2017 report as 37.5h/week, 42 weeks per year.   
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Component Time and Value Estimates Cost Notes 
for every 15,000 patients 
on practice list 
of Nurse time.  
Nurse CPD 8 hours at £41.70 
£334 
(per 15,000 list 
patients) 
Allowance for nurses to attend 
MBRN update sessions and 
encourage practices to release 
nurses for training 
Administration 
15 hours admin time plus 
on costs and leave 
allowance  
minus £10/hour  
per 15k patients on list 
£11,714 
(per 15,000 list 
patients) 
Extra administration is required as 
part of increased diagnosing, MDT 
organisation and post MDT action 
Equipment 
Equivalent to a new 
Spirometer each year 
(£1,500) per 15k patients on 
practice list 
£1500 
(per 15,000 list 
patients) 
In addition to QoF monies an 
allowance for equipment to ensure 
up-to-date and well calibrated 
equipment 
Diagnosis 
1 hour for Band 6 Nurse at 
£41.70 
times new codes in 2017  
 
Based on 2017 new diagnoses, fund 
an hour of Band 6 Nurse time for 
extra diagnostic appointments 
Disease 
Monitoring 
20 mins Band 6 Nurse 
(£41.70 / 3 = £13.90). 50% 
COPD and Asthma patients 
(in addition to QOF) and 
100% BE and ILD patients 
 
Funding for 20 minute reviews for 
ILD and Bronchiectasis patients (not 
provided under QoF), also an 
allowance for extra reviews of 
Asthma and COPD patients, 
particularly complex and 
deteriorating patients 
ICC Respiratory 
Team 
Resources 
£2 per patient on each of 
the 4 respiratory disease 
registers 
 
Funding for wider ICC 
projects/patient resources. CPD for 
community staff attached to ICC 
Locality 
Resources 
20 pence per patient on 
practice list 
 
ICC funding to contribute towards 
locality MDT and community clinics 
(venue/admin/co-ordination) 
Table 6: Cost calculator for General Practice 
 
Based on these costings, the GP population payment calculation for Bundle 1 practices is as 
follows: 
 
ICC 
Queen 
Square 
Bay LMP Carnforth 
Barrow 
Town 
Totals 
List Size 14270 61068 55750 15007 33743 179,838 
COPD 342 1735 1025 333 862 4,297 
Adult Asthma 998 4152 3239 1200 2401 11,990 
Bronchiectasis 71 255 154 93 107 680 
ILD 18 88 45 34 44 229 
New Codes 82 335 315 92 136 960 
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ICC 
Queen 
Square 
Bay LMP Carnforth 
Barrow 
Town 
Totals 
GP Sessional 
Time 
£16,823.47 £72,825.63 £66,483.73 £17,896.35 £40,239.65 £214,268.83 
GP CPD £915.56 £2,800.99 £2,557.07 £688.32 £1,547.68 £8,509.62 
Nurse Time £7,497.74 £32,086.35 £29,292.17 £7,884.98 £17,729.25 £94,490.48 
Nursing CPD £317.36 £1,358.15 £1,239.88 £333.76 £750.44 £3,999.60 
Administration £11,143.92 £47,690.44 £43,537.41 £11,719.57 £26,351.26 £140,442.59 
Equipment £1,427.00 £6,106.80 £5,575.00 £1,500.70 £3,374.30 £17,983.80 
              
Diagnosis £3,419.40 £13,969.50 £13,135.50 £3,836.40 £5,671.20 £40,032.00 
Disease 
Monitoring 
£5,324.10 £22,723.05 £15,771.30 £6,440.95 £12,051.05 £62,310.45 
ICC Resp Team 
Resources 
£2,858.00 £12,460.00 £8,926.00 £3,320.00 £6,828.00 £34,392.00 
Locality 
Resources 
£285.40 £1,221.36 £1,115.00 £300.14 £674.86 £3,596.76 
Total Yearly 
Funding 
£49,726.56 £199,560.91 £177,592.05 £50,301.02 £107,714.83 £584,895.37 
per patient £3.48 £3.27 £3.19 £3.35 £3.19 £3.25 
Table 7: GP population payment calculation 
 
This calculation indicates that the current assessment of £3 per registered patient should be 
revised and increased to £3.25. If we assume this revised figure of £3.25 as GP population 
payment for the purpose of a projection of the cost of delivery of the MBRN, this translates to a 
yearly cost for Bundle 1 practices of £573,970. 
 
If this projection is carried forward to all practices in Morecambe Bay when rollout is 
accomplished and implementation reaches 100%, this arrives at a yearly cost of £1,113,223. 
 
Cost Calculations: Community Services 
 
Community Services around the MBRN have not been implemented at all, so there is no actual 
data on resource use. The following table is a costing projection developed by the delivery group. 
It involves yearly staff requirements and additional costings to support one Community Service 
team for the MBRN.  
 
Additional 
WTE's 
Band Description FY cost 
(at mid-
point) 
0.30 8a Advanced Practitioner £16,975 
1.00 7 Specialist Respiratory Physiotherapist £45,671 
0.90 6 Occupational Therapists £34,259 
0.50 7 Nurse £22,836 
1.00 6 Respiratory Physiotherapist £38,065 
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1.10 6 Respiratory Nurse £41,872 
0.50 3 Therapy Assistant £11,156 
0.70 3 Secretary £15,618 
0.50 4 Smoking Cessation Advisor £13,027 
  
Venue hire £4,000 
  
PR equipment £500 
   
£243,976 
Table 8: Staffing and additional requirements for Community Service Team 
 
For the MBRN to function effectively, the MBRN model includes three Community Service Teams, 
one for each MDT area operating across several ICCs: Barrow and Furness, South Lakes and 
Lancashire North. The projected yearly cost for the three Community Service Teams is therefore £ 
£731,929. 
 
 
Cost Calculations: Secondary Care 
 
The allocation of staff from secondary care is assessed as two respiratory consultants and two 
advanced respiratory nurses to attend the monthly MDT meetings in each of the three locations. 
MDT meetings are scheduled for two hours, added to which is one hour of travel time. 
Additionally, these allocations need to be covered at the hospital with equivalent staff. Based on 
PSSRU data and taking into account the MFF for UHMB, the costs associated with this is 
calculated at £602 per month each for the respiratory consultants and £307 each for the nurses, 
totalling £1,818 per month. This adds up to a yearly cost of £21,821 for each MDT location or 
£65,463 in total. 
 
Summary of MBRN delivery costs 
 
In summary, the cost of delivering the MBRN is calculated to be as follows: 
 
MBRN Summary Monthly Yearly 
General Practice £92,769 £1,113,223 
Community services £60,994 £731,929 
Hospital services £5,455 £65,464 
Total £159,218 £1,910,615 
Table 9: Projected yearly cost of delivery of MBRN 
  
 
 
3.4.4 Impact assessment 
 
The assessment of the impact of the MBRN on healthcare demand and costs is a critical 
component for decision makers. However, as the MBRN has only been implemented for a short 
time, and only partially implemented at that, assessing its impact is difficult. In the following 
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sections, we will present the anticipated impact presented in the planning documents for the 
MBRN and then compare these to two sets of data that are available, one from the Delivery 
Group update in March, and then the latest available figures from the Delivery Group update in 
August.  
 
 
Projected impact modelling 
 
The implementation of the MBRN is anticipated to primarily impact on hospital inpatient and 
outpatient service demands. This is encapsulated in Bundle 3 of the MBRN service offering  
reduction in UHMB specialist respiratory capacity including outpatient clinics and bed capacity.  
 
The three main KPIs for this model are:  
 Reduce Outpatient Attendances by 50%, (excluding technician-led respiratory 
physiology), based on audit of clinic appointments and agreement between UHMB 
consultant and GP clinical leads  
 Reduce Non-Elective admissions by 20% for the clinical conditions / patient 
cohorts listed below, as demonstrated by a recent pilot of elements of the 
proposed model of care in Barrow: 
o COPD 
o Asthma 
o Bronchiectasis 
o IPF/ILD 
o Plus exacerbations of the above conditions presenting as pneumonia/LRTI 
 
 Reduce Emergency Bed Days by 50%  (phased 25% by end 2018, 25% by end 2019) 
for the same conditions, based on the same pilot 
 
The Maximum projected impact on capacity is: 
 - 15 occupied beds 
 - 9 clinic sessions per week 
 
In these plans, a two month’s delay was anticipated from the start of implementation to any 
impact. Furthermore, it is anticipated that once the MRBN is operational in each locality within 
Morecambe Bay the changes will be self-funding and indeed will generate savings for the whole 
health economy and facilitate the re-utilisation of resources in the community rather than in the 
hospital. 
 
The original service specification31 identified patient cohorts and opportunities for inpatient and 
outpatient activity. 
 
                                                             
31 BHCP (2017). Morecambe Bay Respiratory Network – Identification of patient target cohorts and 
quantification of potential benefits. 
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Inpatient cohorts and opportunity 
 
 
Table 10: Inpatient cohorts 
  
 
Table 11: Inpatient patient opportunities 
 
Opportunities to reduce NEL admissions and NEL bed days for the identified patient cohorts are 
based on: 
 Aiming to achieve zero emergency readmissions for known patients (more than 1,000 of 
the 1,661 target admissions were admitted as an emergency within the previous year) 
 Reductions demonstrated via Barrow Town PDSA during 2016/17 Q4 
 
Per year across the Trust, this would equate to: 
 Avoiding 1-2 acute admissions per day 
 Releasing up to 14 occupied beds (based on assumption of 100% occupancy) 
 
Bundle 1 ICCS account for roughly half of the total opportunity, which means: 
 Up to 1 acute admission per day on average 
 1-2 occupied beds at FGH 
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 5-6 occupied beds at RLI 
  
 
This would translate to the following reductions in absolute numbers: 
 
 NEL admissions (FYE 
assuming 100% 
implementation) 
NEL Bed Days (FYE assuming 
100% implementation) 
Bundle 1 - 177 - 2,703 
Bundle 2 - 155 - 2,375 
Total - 332 - 5,078 
Table 12: Reduction in inpatient activity in absolute numbers 
 
 
Outpatient cohorts and opportunity 
 
Analysis of UHMB referrals, outpatient activity and waiting lists indicates recurrent annual 
respiratory demand of: 
 2,800 new patients 
 5,400 follow up appointments 
 
This activity is currently seen in secondary care and includes consultant- and nurse-led clinics but 
excludes technician-led clinical physiology. Clinical coding suggests that the majority of this 
activity consists of: face-to-face consultations, simple airflow and gas exchange studies, oxygen 
assessment and monitoring, respiratory nurse and AHP education/support.  
 
 
Table 13: Outpatient cohorts 
  
 
Table 14: Outpatient opportunities 
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The modelled clinic session requirements in the table above (e.g. 60 hours = 15 half-day sessions 
per week) are based on the RCP-recommended allocation of 30 minutes per new patient and 15 
minutes for FUPs, allowing for 10%DNA and 42 working weeks per year. 
 
While it is accepted that the majority of this activity may not need to be seen in a hospital setting, 
there will need to be a balance between the volumes that could be re-provided out of hospital, 
the capacity available in primary care and community settings and the capacity required to 
maintain a hospital-based acute respiratory service.  
 
At an agreed modelling assumption of 50% reduction for both first and follow up appointments, 
this would translate into the following reduction in absolute figures: 
 
 First appointments (FYE 
assuming 100% 
implementation) 
FUPs (FYE assuming 100% 
implementation) 
Bundle 1 - 711 - 1313 
Bundle 2 - 625 - 1153 
Total - 1337 - 2,466 
Table 15: Potential reduction in outpatient activity 
 
It has to be noted, however, that these figures are based on the implementation of the whole 
MBRN model, which at the point of planning included the implementation in April 2018 of Bundle 
2 and the commencement of Community Services as the vital third pillar of the MBRN delivery 
plan. As neither of these have happened yet, realistically, a lower impact has to be expected.    
 
Update March 2018 
 
The first impact figures for the MBRN were available in March. Monitoring of KPIs is expected to 
be conducted via the MBRN dashboard once this is fully up and running. In the absence of the 
dashboard, in this evaluation, we have to rely on data from the delivery group, which is 
presented below. This is taken from the BHCP Delivery Group update document from March 
2018. This data therefore refers to figures up to and including January 2018.  
 A clinical review of the original target conditions as part of the roll out of Bundle 1 
narrowed the patient cohorts that are being prioritised by the MBRN. Patients aged 19 
years or over with COPD, asthma, bronchiectasis, and IPF/ILD have been included in the 
capacity modelling assumptions. Conditions such as pneumonia and lower respiratory 
tract infections are not within the initial scope of the MBRN but may be included at a later 
stage.  
 
 It is worth noting that there are 1,500 patients waiting for a follow up appointment as 
part of the respiratory IRD backlog. Reducing this figure is critical if there is going to be 
capacity reduction as part of the new model and the trust is currently exploring options 
to deliver a step change in this number with i3 support. The bundle 1 practices have been 
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issued with their current list of patients under active follow up and it may be possible to 
discharge some of the cohort to primary care without being seen in UHMB.  
 
 We also need to be aware of the impact of the e-RS work stream on this area of our 
activity as it could further dilute this modelling assumption on current demand and 
capacity. 
 
A comparison of GP referral activity for Bundle 1 and Bundle 2 practices was presented in the 
Delivery Group update document, which is reproduced here: 
 
 
Figure 3 Comparison of New GP Referrals Growth Yr on Yr 
 
As shown above, the reduction of new GP referrals to UHMB since October 2017 in the bundle 1 
practices amounts to a 31% reduction on the previous year and compares well with the 37% 
increase in GP referrals seen over the same period in the bundle 2 practices and the 27% increase 
in referrals in the bundle 1 practices from January to September 2017. The absolute reduction in 
GP referrals in the bundle 1 practices when compared to the bundle 2 practices is 162 referrals 
between October 2017 and January 2018 as shown in the next section.  
 
Reductions in referral trend in Bundle 1 practices compared to Bundle 2 practices were also 
presented: 
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Figure 4 New Bundle 1 Referrals and Reduction Compared to Bundle 2 
 
The charts on the following pages show that total respiratory outpatient activity on all three 
UHMB sites remains largely stable as the reduction in new GP referrals from the bundle 1 
practices has allowed the department to reduce their backlog on follow up appointments and 
also provide increased access to for referrals from other consultants which make up 40% of all 
new respiratory referrals. 
 
 
Figure 5 UHMB new outpatient activity trend – all sites 
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Figure 6 UHMB new outpatient activity trend – FGH 
 
 
Figure 7 UHMB new outpatient activity trend – RLI 
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Figure 8 UHMB new outpatient activity trend – WGH 
 
The initial evaluation of non-elective respiratory activity within UHMB during the bundle 1 
implementation phase has concluded that there has been no reduction in activity. In fact, there 
has been a slight growth in respiratory activity above the general levels of acute activity growth 
over the winter. 
 
Given the impact of seasonal flu this year it is understandable that no reduction in non-elective 
activity has been seen. It should also be noted that no reduction in non-electivity was anticipated 
or planned for by the MBRN team as the key interventions in the community services needed to 
deliver such reductions have not been implemented in the bundle 1 roll out. 
 
Update August 2018 
 
Data for this update stems from MBRN Steering Group update to the CCG Executive in August 
2018 and from the BCT MBRN Respiratory Presentation in June 2018.  
First of all, this reports in the restrictions in the roll-out of the MBRN: 
 Investment is limited and recruitment is an issue due to funding uncertainties, restricting 
implementation to Bundle 1 ICCs only 
 Commenced in November 2017 
 Integrated community clinics (MDTs) 
 Community Services to support early discharge and prevent admission are not in place  
 
Despite these severe limitations in the implementation of the MBRN, impact measurements are 
showing an effect. GP referrals are reducing slightly overall: 
 
51 
 
 
Figure 9 New Respiratory Referral Activity Trends 
 
This reduction can be mainly attributed to reducing GP referrals in Bundle 1 ICCs. GP referrals in 
the Bundle 1 ICCs are showing a significant downward trend. The following two graphs show GP 
referrals for Barrow Town ICC (South Cumbria) and Lancashire North ICCs (all Bundle 1): 
 
 
Figure 10 New Referral Activity Trends: Barrow 
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GP referrals are reducing even faster in the Lancashire North ICCs:  
 
Figure 11 New Referral Activity Trends - North Lancs 
 
 
Total Outpatient activity remains static, as capacity reductions have not been implemented and 
any reduction in GP referrals have been absorbed into reducing unmet outpatient demand.  
 
53 
 
 
Figure 12 Outpatient Activity Trend 
 
 
Across Morecambe Bay, last winter saw a significant increase in both admissions and length of 
stay: 
 
 
Figure 13 Inpatient Activity Trend 
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Bundle 1 ICCs, however, see an overall falling trend in LoS after the beginning of the MBRN 
implementation. 
 
 
Figure 14 Bundle 1 Inpatient Activity Trend 
 
 
This trend is more pronounced in the Lancashire North ICCs. 
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Figure 15 North Lancs Inpatient Activity Trend 
 
 
This trend is set against a trend of increasing LoS in the Bundle 2 ICCs (where the MBRN is not 
implemented at all yet). 
 
 
Figure 16 Bundle 2 (not implemented) Inpatient Activity Trend 
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Revised Plans July 2018 
 
Due to the severe resource constraints and subsequent restrictions on the implementation of the 
MBRN (see above), the delivery plans were revised in July 2018.  
 
Figures on new GP outpatient referrals from practices involved in the MBRN show that there is an 
overall 40% reduction. Outpatient attendances remain have not reduced as clinic capacity remains 
static. Inpatient activity has also not reduced as this can only occur when the community 
elements of the MBRN are introduced. 
 
With this in mind, the impact assessment has been revised to the following for Bundle 1: 
 
 Outpatients first appointment  
 
 Impact Summary:  
o Reduction of 379 first appointments 
o Equating to 47 clinics per year, which equals a net reduction of 6 clinics per month 
o Assuming a similar reduction in follow-up appointments, this would equate to a 
reduction of 20-30 clinics per year 
 
 Inpatient NEL admissions 
 
 Impact Summary: 
o Reduction of 174 non-elective admissions 
o Equating to 513 beddays, which would equate to a net reduction of 4 beds over 2 
years 
o If taking into account a falling LoS (as indicated in figures above), and assuming 
LoS at 7 days, this would equate to a reduction of 9-10 beds over 18 months.  
 
 
3.4.5 Financial implications of impact 
 
Taking data provided by the Delivery Group and UHMB business intelligence, possible savings on 
secondary care spending are presented in this section.  
 
Costings are based on PbR Tariffs 2017/1832 and additional information from Respiratory Coding 
and Tariff Update 2017/201833: 
                                                             
32 National Tariff Payment System 2017/18. Available at: https://improvement.nhs.uk/resources/national-
tariff-1719/ [Last accessed 18/09/2018] 
33 British Thoracic Society (2017). Respiratory Coding and Tariff Update 2017/2018. Available at: 
https://www.brit-thoracic.org.uk/document-library/delivery-of-respiratory-care/coding/respiratory-coding-
and-tariff-update-2017-2018/ [Last accessed 18/09/2018] 
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 NEL admission costs are calculated as an average of the PbR spell tariff for all conditions 
in scope. This arrives at a cost of £2,983 per admission. 
 
 Excess bed days for NEL respiratory spells are given as £208.  
 
 Outpatient first admissions costs are calculated as an average of applicable codes, i.e. 340 
(respiratory medicine) and TFC341 (pulmonary function testing), as laid out in the 
Respiratory Coding and Tariff Update. This arrives as at cost of £218 per first outpatient 
appointment. 
 
 Follow-up appointment costs are calculated in the same way, arriving at £129 per FUP.  
 
For the scenario of full implementation achieving the predicted impact in terms of NEL admission 
reduction, bed day reduction and outpatient appointment reduction, this would generate the 
following tariff reductions: 
 
 
Tariff 
Projected 
Reductions Tariff reduction 
Non-Elective admissions £2,983 332 £990,432 
Length of Stay £208 5078 £1,056,224 
First Out-Patient £218 1337 £291,132 
Follow-up Out-Patient £129 2466 £316,881 
Total 
  
£2,654,669 
Table 16: Secondary tariff reduction for full implementation and impact scenario 
 
Taking into account the cost of delivering the MBRN as calculated above, we arrive at the 
following financial cost/benefit analysis: 
 
 Per Month Per Year 
MBRN delivery cost £159,218 £1,910,615 
Tariff reduction -£221,222 -£2,654,669 
Net saving -£62,004 -£744,054 
Table 17: MBRN delivery cost vs. tariff reduction based on predicted impact 
 
These calculations would indicate that the MBRN is not only self-funding, if the reduction in 
hospital activity is translated into an actual reduction in capacity, but there is a potential for 
savings of around three quarters of a million pounds per year.  
 
As the above calculations are based on projected figures, the following presents the same 
calculations based on the current state of implementation. For the MBRN delivery costs, only the 
proportion of Bundle 1 GP population payments and hospital staff MDT participation are taken 
into account. Furthermore, as community services are not in place yet, these are taken out of the 
delivery costs.  
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Tariff 
Projected 
Reductions Tariff reduction 
Non-Elective admissions £2,983 174 £519,082 
Length of Stay £208 513 £106,704 
First Out-Patient £218 379 £82,527 
Follow-up Out-Patient £129 699 £89,821 
Total 
  
£798,134 
Table 18: Secondary care tariff reduction actual 
 
 
 Oct 17 to Aug 18 
MBRN delivery cost £596,480 
Tariff reduction £798,135 
Net saving -£201,655 
Table 19: MBRN delivery cost vs. tariff reduction actual 
 
This would indicate, that despite the severely curtailed implementation and short running time, 
the MBRN has already had a financial impact on the health system. It is acknowledged, however, 
that at the moment, these are not real-term savings, as no capacity reduction has occurred in 
secondary care. 
 
 
3.4.6 Summary of Analysis and Limitations 
 
 From the data that is available for this evaluation, the running cost of the MBRN has been 
calculated as amounting to approximately £1.9m pounds year, or £160k per month.  
 
 Possible tariff reductions in secondary care from reduced NEL admissions and NEL bed-
days as well as reduced outpatient clinic capacity amount to over £2.6m per year, or £221k 
per month. This would arrive at a net savings to the health system of approximately 
£745k per year, or £60k per month. 
 In summary, all indications point to the MBRN being a cost-effective step change in 
delivering respiratory services in the Morecambe Bay area. 
 
 The calculations are based on reasonable assumptions, but there are several limitations 
from lack of data that could affect the costings: 
 
Data Issue Effect Recommendations 
 
Only Bundle 1 is operative so far, 
and the community service 
element is missing entirely. All 
bar one ICC in Bundle 1 is in 
North Lancashire, all Bundle 2 
ICCs are in South Cumbria.  
 
 
It is uncertain how the costings 
of the MBRN to local ICCs 
extrapolate from Bundle 1 to 
Bundle 2.  
 
Whilst Bundle 1 contains 
predominantly big practices in 
 
It has been identified that the £3 
per list patient GP population 
payment should be raised to 
£3.25. 
 
It is recommended that further 
work is completed before a 
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more urban areas, Bundle 2 
contains predominantly smaller 
practices in more rural areas that 
would have to pool resources in 
Primary Care Networks (PCNs) 
for providing additional MBRN 
services.  
 
move to a differential 
investment formula can be made 
across all practices in 
Morecambe Bay. 
 
 
There is a lack of precise data on 
which positions are funded from 
which sources.  
 
It is not possible to determine 
whether these are recurrent or 
non-recurrent funds, and how 
much of the time spent on 
MBRN activities exactly is 
additional, backfilled or carried 
out on goodwill during the 
staffs’ time off.  
 
This makes it extremely difficult 
to precisely calculate the running 
costs and funding needs of the 
MBRN. 
 
 
From the Delivery Group update 
in March 2018 we know that 
£180k of non-recurrent 
enablement funding was not 
included in the original MBRN 
proposal considered by Delivery 
Group, as this was being funded 
through the non-recurrent 
support to General Practices bid 
to NHS England. This essential 
funding has been lost and will 
require replacing.  
 
Dedicated funded clinical 
leadership will be required to 
complete the implementation of 
the MBRN.  
 
Dedicated project management 
will be required to support 
clinical network leaders and PCN 
clinicians. The exact nature of 
these positions in financial 
terms, however, is unknown. 
 
 
The fact that the data dashboard 
is not available yet makes 
monitoring of KPIs difficult, 
which in turn affects the 
accuracy of cost/benefit 
analyses. 
 
An additional KPI that will be 
part of the dashboard data is 
prescribing. From the Delivery 
Group presentation on potential 
ROI of the MBRN (BHCP 2016), 
we know that “Right Care 
identified an opportunity of 
£700k (FYE).” The target 
reduction of 50% FYE would 
therefore equate to potential 
savings on prescribing of £350k.  
 
As no data is available on this at 
present, this cannot be factored 
in to the economic analysis.  
 
 
The qualitative analysis of the 
MBRN indicates that the new 
pathways improve diagnostic 
accuracy and prevent 
exacerbations, which should 
have a significant impact on 
prescribing, as the prescription 
of unnecessary, unsuitable and 
ineffective medication is 
reduced. 
 
The indications from data that is 
available on the performance of 
the MBRN so far are positive.   
 
 
 The economic evaluation, however, has also shown that in order to deliver the savings 
to the health economy that are certainly possible through an effective MBRN, it has to 
be fully implemented.  
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 Even in its short life span, there is good evidence that the MBRN delivers savings from 
reduced hospital activity. However, the slow progress in implementing the community 
aspects of the MBRN model will have a knock-on effect on high-level outcome figures, 
particularly regarding hospital admissions. For example, waiting times of over 8 months 
for pulmonary rehabilitation services in Barrow has resulted in many patients being 
admitted to hospital, where they could have been adequately maintained in the 
community, given a working community respiratory service infrastructure. 
 
 One key element to this is the role of non-recurrent funding (whether vanguard or other) 
in establishing the model. For example, the non-recurrent funding identified so far has 
not permitted the CPFT and BHT community teams to advertise for additional staff. In 
addition, the impending move of services to UHMB has reduced the availability of 
managers to work with the MBRN lead clinicians to accurately specify the additional roles 
and capacity that will be required to fully implement the MBRN model. 
 
 This analysis suggests the full MBRN model (including Primary Care services, Community 
services and Secondary Care services) will be able to be self-funding, or even cost saving; 
but recurrent funding will be needed to establish thus. A possible source of this funding is 
if the reduced activity benefits in secondary care translate into funding of the GP and 
community service elements of the MBRN. 
 
3.5 What are the ‘active ingredients’ of a care model? Which aspects, if replicated 
elsewhere, can be expected to give similar results and what contextual factors are 
prerequisites for success? 
 
 
3.5.1 Active Ingredients Comparison 
 
In the 12 Month Report, data analysis suggested that there were four key ingredients for 
implementing new models of care in Morecambe Bay. The data from the Stage 2 evaluation 
suggests that while these ingredients are also active within the MBRN model, its implementation 
has found ways through some of the disabling aspects of these themes. These are shown in the 
following table:
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Active Ingredient 
 
BCT-wide Findings
34
 
 
 
 
MBRN FIndings 
 
 
Leadership 
 A strong picture to emerge from participants’ accounts 
was the notion that a top-down model of leadership 
was inappropriate for the changes being attempted. 
The data as a whole lacked strong examples of 
overarching system-wide leadership, and frustrations 
were reported with a lack of transparency over 
decision-making at higher levels. 
 
 The enabling mechanisms of leadership identified by 
participants reflected more of a model of localised, 
collective leadership. However, the focus on 
incremental, localised 
 
 Changes often struggled to be clearly related to a 
larger-scale and strategic models of change.  
 
 The MBRN model required key individuals to drive the 
initial process of change with a clear vision. The model 
was built as a “network” rather than a “system”, which 
enabled the changes to develop iteratively as they 
enlarged, with consistency provided by a core 
leadership group. This has, to date, provided a way of 
negotiating the tensions between localised delivery and 
strategic direction that BCT encountered.  
 
 Enabling this also required “buy-in” and degrees of 
good will from managers and clinicians in order to 
maintain the process of change.  
 
 
 
Communication 
 Communication was a multi-dimensional theme, 
including: 
o Clarity of strategy and direction 
o Multi-directional feedback loops to inform 
decision-making 
o Localised conversations between both staff, 
and organisations more generally 
 
 The growth of the MBRN has been characterised by an 
openness and willingness to learn from the expertise 
held by other NHS staff, and to understand patients 
from a holistic perspective.  
 
 This is rooted in the provision of structured 
opportunities for the bring-together of knowledge, 
                                                             
34 See HASCE (2017), Local Evaluation of Morecambe Bay PACS Vanguard: 12 Month Report, pp. 143-152 
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o Communication with patients and public. 
 
expertise and learning to take place. In particular, the 
MDTs have been reported as providing a mechanism 
through which NHS staff can come together and 
develop an understanding of the roles of others. In 
doing so, they have broken down the barriers to 
communication between primary, secondary and 
community care services. 
 
 
k 
Cultural Change 
 The data suggested that while participants fully 
understood the reasoning behind proposed changes, 
and the need for new models of care to be 
implemented, there was often a lack of tangible 
evidence to demonstrate changes in culture. 
 
 The theme of increased trust in the ability of other 
clinicians to effectively manage patients and reducing 
the need for follow up hospital appointments has been 
recurrent throughout the data. The tangible outcomes 
of the network have been key to this shift. 
 
 It must be remembered, however, that the MBRN has 
yet to be rolled out into Bundle 2. This may present new 
challenges around bringing together different 
organisational cultures.  
 
 
 
Necessary Tensions to 
Negotiate 
 The delivery of the vanguard at a system-wide level 
faced several tensions that were a necessary product of 
the process. These included: 
o Localised delivery vs whole system change 
o Project-based work (i.e. non-recurrent funding) 
vs long-term sustainable work 
o Focus on efficiencies vs focus on “upstream 
care” 
 
 
 Tensions remain regarding how the non-recurrent 
funding used to establish the MBRN can be replaced. 
 
 The model has demonstrated its capacity to be self-
funding, with sufficient investment. 
Table 20 Active Ingredients of an NCM – comparison of evaluation stages 
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3.5.2 Integrated Care and Knowledge Ecology 
 
 Data analysis suggests that the fundamental active ingredient for the new model of care 
the MBRN represents is the bringing together of knowledge expertise in order to 
facilitate integrated care.  
 
 The data suggests that this bringing together does not necessarily follow a linear 
structure. In order to deliver an iterative and integrated service, it is perhaps better to 
think of a new care model as less a linear structure, and more of the facilitation of an 
ecology of knowledge and expertise, from both clinicians and patients, which results in 
improved clinical outcomes and self-care. 
 
 This “ecological” account of a new care model does not always fit with the traditional 
focus on outcomes and linear pathways within health provision; nor, indeed, to some of 
the logic models applied in the 12 Month Evaluation. It requires understanding an NCM as 
more than simply a design on a page, and more of a collective endeavour which arises out 
of interactions between different parts of the existing system. One way to illustrate it is 
through the following diagram:  
 
 
 
Figure 17 Ecological account of a new care model 
 
 
 Here, the core enabler of the model is seen as activities and outcomes reflecting the 
bringing-together of knowledge and expertise from different areas in tangible ways. 
These are pulled together from two, often opposed directions: on the one hand, 
structural and technical themes, and on the other hand, themes related to personal 
qualities, traits and assets. 
 
 From the data collected for this evaluation we can identify that at either end of this 
continuum are the main disablers for the new model of care: for example, issues around 
funding and capacity are structural aspects of care, embedded within larger systems of 
practice, information and governance. Likewise, geography and demographics are 
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structural issues which have previously contributed to the higher rates of respiratory 
problems in the population. At the other end, the need for “buy-in” from staff and 
managers can be seen as a personal aspect of the system, as it involves an engagement 
with the ethos of the MBRN model.  
 
 However, when structural and personal aspects are brought together as enablers, the 
result is the facilitations of shared knowledge and expertise, which results in a more 
integrated model of care. We can thus understand how the “active ingredients” arising 
from the Stage 2 evaluation, both enabling and disabling, take a clear shape when 
considered along this continuum. This is represented in the following diagram: 
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Key contexts  Geographical, 
historical and 
socio-economic 
demographics 
Differences in 
potential roll-
out to other 
areas 
Clear need for 
improvement 
in respiratory 
conditions 
across 
Morecambe 
Bay 
Awareness of 
social aspect of 
conditions (e.g. 
need for good 
“back up 
teams” for 
patients) 
Leadership, 
motivation and 
enthusiasm 
 
Autonomous 
development 
of model 
 
Reporting 
techniques 
Outcomes that 
‘matter’ not 
always 
captured by 
existing 
reporting 
techniques 
 
Reporting 
often guided 
by QOF 
requirements 
Improved IT 
and 
information 
sharing, e.g. 
EMiS Template 
Indications of 
positive 
change in 
outcome data 
 
Diagnosis and 
medication 
reviews 
 
Improved self-
understanding 
and self-care 
reported by 
patients 
 
Improved 
communication 
between 
practices 
Open-ness to 
learning and 
sharing 
expertise 
within 
individuals 
Staffing, roles 
and resources 
Lack of 
capacity, and 
potential for 
MBRN to 
increase 
burden 
 
Recruitment 
and attrition of 
key staff 
 
Identification 
of leads and 
teams 
 
Partial 
implementation 
of model due to 
funding 
 
MDTs 
 
Upskilling staff 
 
“Learning 
points” arising 
through MDTs 
Engagement 
from leads and 
wider teams 
 
Investment of 
additional time 
by individuals 
Improved 
communication 
between 
patient and 
clinicians, and 
between 
MBRN 
participants 
Traditional silo 
working  
Continuity of 
care from a 
patient 
perspective 
 
Involvement in 
a pathway 
 
 
MDT allows  
 
Holistic view of 
the patient  
Increased staff 
confidence 
that patients 
aren’t ‘falling 
through the 
gaps.’ 
 
Importance of 
trust, including 
patient’s trust 
in clinicians 
Figure 18 Active Ingredients in the MBRN model 
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3 Conclusion and Recommendations 
 
 
4.1 The Morecambe Bay Respiratory Network 
 
 The evaluation of the MBRN to date has shown it to be a successful new model of care, 
with the potential to become a self-funding initiative which reduces secondary care 
activity, improves self-care amongst patients and enhances the learning and upskilling of 
staff. 
 
 The model has developed ways of overcoming a number of problems and tensions 
identified with the implementation of NCMs in the 12 Month Report; in particular, its 
model of leadership and its emphasis on communication. 
 
 Therefore, the evaluation recommends that the model is continued to be supported by 
Bay Health and Care Partners. The economic evaluation has also shown that in order to 
deliver the savings to the health economy that are certainly possible through an effective 
MBRN, it has to be fully implemented, including its community services.  
 
 However, the expected roll-out of the model has been delayed during the timespan of 
the evaluation, and the absence of funding for community care has meant that the model 
is yet to be fully realised. This means that comparison sites have not been available to 
evaluate. While data suggests that the model has been successful for those stakeholders 
who participated in the evaluation, the evaluators did not have access to non-engaging 
stakeholders. 
 
 With this in mind, the following recommendations can be made for the future delivery 
and rolling out of the network model. These recommendations have been formed both in 
response to the analysis presented in this report and in the Stage 2 Early Findings Report, 
and also following a dissemination workshop with participants in the evaluation, held in 
September 2018, to discuss emerging findings and draw out key messages. 
 
 A key active ingredient for the success of the model has been the enthusiasm and 
drive of individuals involved. Because of this, it is important to acknowledge and 
explore any local resistance to adopting the model within different ICCs, as it is 
unlikely to succeed where the underlying ethos of the MBRN is not also adopted. 
 
 Implemented new ways of working will benefit from agreed timescales amongst 
service deliverers, as well as clear access to resources and information about the 
MBRN. 
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 There is a strong need to develop agreed frameworks for the quality and 
consistency of delivery, in order to ensure that the benefits of the model 
experienced in some areas are shared across Morecambe Bay. This will include 
acknowledging the limitations of previous reporting techniques, and adopting 
agreed approaches to data collection and analysis.  
 
 Capturing the multi-dimensional nature of respiratory data is crucial. Therefore, 
following data through patient cohorts as well as higher-level outcomes will allow 
the changes taking place via the MBRN to be identified. Linking clinical data with 
broader quality of life data will also be beneficial.  
 
 Likewise, it is important to continuously seek ways of measuring patient 
understanding and confidence, so that self-care can be improved. 
 
 The new model of care creates what is described in Section 3.5.2 above as a 
“knowledge ecology.” It is recommended that this ecology continues to evolve, 
particularly in regard the dialogue between service users and clinicians: the use of 
patient groups, peer support groups and so on may help to facilitate this. 
 
4.2 New Care Models in Morecambe Bay 
 
Alongside the recommendations above, as well as those presented in the 12 Month Report and 
the Stage 2 Early Findings Report, the following general conclusions and recommendations can 
be drawn at the close of this two-year evaluation project on New Care Models in Morecambe 
Bay. 
 A new model of care is rarely entirely “new”, in that it is shaped and formed through 
historical and contextual aspects. These contexts can often lead to embedded behaviours 
and ways of working at both structural and personal levels. The design of an NCM must 
be alert to how it intends to change these contexts in order to enable the model of care 
to succeed. 
 
 The recurrent theme of all successful NCM initiatives within this evaluation has been 
communication, frequently beginning with local conversations and bringing different 
organisations into dialogue. 
 
 This means that the process of implementing new models of care is not linear, and often 
involves finely balancing a number of necessary tensions. Models which are implemented 
from the “top down” are less likely to be effective than localised and iterative practices. 
Localised integration of care which is then modelled and expanded has shown a more 
productive outcome. 
 
 At the same time, this requires an NCM to have the capacity for clear feedback loops, so 
that issues such as non-engagement, resistance or failure can be explored and analysed. 
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 Delivery of NCMs requires strong leadership, both at programme-level and at more senior 
levels. This includes the capacity to acknowledge and reflect on failings as well as 
successes; to use evidence and data in appropriate ways for the complexity of the 
Morecambe Bay health economy; and to provide transparency and timeliness with 
decision-making. 
 
 A key success to the MBRN to date has been its development of a learning culture within 
respiratory care. There remain specific obstacles to this being reproduced at a wider 
level, which has a subsequent effect on the capacity for improvement. To address this, it 
is recommended that new initiatives provide clear yet contextualised KPIs, utilising a 
range of evidence sources that go beyond high-level outcomes.  
 
 Evaluation must be embedded in programmes and initiatives from the earliest point. 
While certain outcomes and measures may be considered more prescient (e.g. financial 
savings achieved), there is a strong need for evaluation to support these with 
complimentary measures and analyses, such as changes in culture, perceptions of care 
and qualitative effects. This will support evidencing the longer-term sustainability of new 
models of care. 
 
 
